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CHAPTER 1  INTRODUCTION1          
                       
1.1. Introduction 
 
Many demographers who analyze mortality changes over time in low-
mortality countries share two common views. On the one hand, that most 
of the gain in life expectancy before the first half of the twentieth century 
was due to large reductions in mortality early in life and on the other hand 
that recent and future gains in human life durations are and will be mainly 
due to mortality decline among the elderly. As a consequence, in recent 
years more attention has been paid to adult mortality and especially to 
that of the very old. The subject is likely to be the scene of a lively 
renewed debate, because the growing number and proportion of elderly 
has very important implications for social policy. 
 
This Phd research report (tesina) aims to obtain a better understanding of 
the recent changes in mortality of the elderly population in developed 
countries2.It’s essence will be a critical thinking, without performing 
empirical work, which means that the analysis and concepts of the actual 
demographic literature will form the main body of this work. It basically 
reviews and discusses the recent work on old age mortality that was 
published between 1980 and 2006. However, some older work is evoked 
                                                 
1 Anna Cabré Pla (2000) El País Semanal, nº 1224.12 de marzo de 2000. 
“In Spain we are few demographers, and the demography does not get to be a science, is the art to 
keep awake mysteries and to solve paradoxes” 
 
2 The developed countries include those of Europe and North America, as well as Australia, New 
Zealand and Japan. 
“En España somos poquitos demógrafos, y la demografía no 
llega a ser una ciencia, es el arte de desvelar misterios y 
resolver paradojas” 
              Anna Cabré1 
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given its continued importance today (e.g. Vincent 1951; Greenwood & 
Irwin 1939; Gompertz (1820, 1825, 1862,1872)). 
 
The literature aims to list research issues examined recently and to identify 
still unanswered questions that should be investigated in the years to 
come. There are two central questions: “Which age and cause specific 
mortality trends caused these recent changes in the life expectancy?” and 
“Did the increase in life expectancy of the elderly population accelerate, 
continue or decline in recent years? 
 
In order to answer the first question, the evolution of recent mortality 
developments at older ages are discussed in terms of the Epidemiological 
Transition, the Compression of Mortality, the Limit of Human Life Span and 
the Rectangularization of the Survival Curve. From a theoretical point of 
view the Biodemography, the Evolutionary Theory of Senescence and the 
Reliability Theory of Ageing are analysed and finally there is a review of the 
existing mathematical models of old age mortality in developed countries. 
Although the PhD Research Report is entirely dedicated to these issues, a 
brief introduction to each of them is provided in the following sub-section. 
 
 
1.2. Theoretical background to old age mortality 
 
Epidemiological Transition Theory 
 
During the Epidemiologic Transition changes in the cause-of-death pattern 
from mainly infectious diseases and external causes of death to chronic 
diseases were accompanied by a shift in the age pattern of mortality from 
younger towards older ages. During the third stage mortality began to 
concentrate at the older ages and was mainly caused by chronic diseases. 
The objective of this theory’s analysis is to study the trend of the last stage 
of the epidemiologic transition in developed countries, and to find out the 
extend to which this fourth stage, during which deaths by degenerative 
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diseases are postponed to older ages, has been experienced, and if we are 
heading to, or already in, new stages. 
 
The study of the Epidemiological Transition Theory allows a better insight 
of the processes behind the trends in mortality and causes of death in 
developed countries.  
 
Compression of mortality 
 
Mortality is defined as being compressed when there is a decrease in the 
variability of the age of death. Regarding the history of compression of 
mortality there exist sufficient evidence to prove that the transition from 
high to low mortality was accompanied by large compression of mortality, 
with deaths occurring at older ages and in an increasingly narrower age 
range. Today in developed countries the middle half of the distribution of 
age-specific deaths is concentrated in a range of about 15 years, usually 
somewhere between ages 75 and 90.  
 
Long-term changes in the variability of age at death had significant effects 
on the perceptions, attitudes, and behaviours of individuals and, in turn, on 
society in general. Thus, these broad consequences of the historical 
compression of mortality merit a fully detailed analysis to understand the 
continuous decline of old age mortality in developed countries. 
 
The human life span limit 
 
A fundamental question in ageing research is whether humans and other 
species possess an immutable life-span limit, as the world record of human 
life-span seems to continue moving upward over time (Oeppen & Vaupel 
2002). Projections of duration of life for humans based on mathematical 
models have led some researchers to claim that there is no lower limit to 
death rates or upper limit to life expectancy, and that a life expectancy of 
100 will be achieved in the 21st century (Carnes, Olshansky & Grahn 
2003). Two important questions arise from these observations. First, has 
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this upward trend been stable over time, or has it changed pace in recent 
years? Second, what explains the increase in the maximum age at death?  
 
Rectangularitzation of human survival curve 
 
Rectangularization is defined as a trend toward a more rectangular shape 
of the survival curve due to increased survival and concentration of deaths 
around the mean age at death. That is, the variability in the age at death 
declines and deaths are being compressed into upper years of life. After 
Fries introduced the concept of rectangularization of the survival curve 
(Fries 1980), the question of whether there is or not rectangularization and 
how to measure it has been addressed in several studies (Fries 
(2002,1984); Cheung 2001; Yashin et al. 2001; Coale 1996; Manton & 
Stallard 1996; Eakin & Witten 1995; Go, Brustrom, Lynch & Aldwin 1995; 
Rothenberg, Lentzner, Parker 1991; Myers & Manton 1984). 
 
Because rectangularization is necessary for mortality decline on old age, 
the development of a better understanding of the rectangularization of the 
survival curve at older ages in developed countries plays an important role 
in this research. 
 
Biodemography 
 
Biodemography proposes explanations for life table patterns in human 
populations that are not evident in the absence of broader biological 
concepts. For example, it provides explanations of sex differentials in life 
expectancies, whether life span limits exists, and also of the deceleration 
of mortality at older ages that has been observed in virtually every large-
scale life-table study on insects. Hence, there are strong biological 
arguments for the analysis of the law of mortality and the search for better 
explanatory models. 
 
The emerging field of biodemography will provide the context, perspective 
and a frame of reference for the interpretation and modelling of human 
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mortality data and it will set a new light on those factors correlated with 
the survival history of our species and those factors that explain 
demographic variations between populations. 
 
Evolutionary Theories of Ageing  
 
After twenty years of experiments testing the evolutionary theories of 
ageing, we could accept them because they currently offer the most 
plausible explanation of ageing (Le Bourg 2001), as they try to explain the 
remarkable differences in observed ageing rates and longevity records of 
different biological species (compare, for example, mice and humans). 
Evolutionary explanations of ageing are based on three major evolutionary 
theories: the theory of programmed death (Weismann 1882), the theory of 
the accumulation of mutations at old age (Medawar 1951), and the theory 
of antagonistic pleiotropy (Williams 1957). 
 
It would seem that the evolutionary theories of ageing, currently offer the 
most plausible explanations of ageing. 
 
Reliability Theory of Ageing 
 
Reliability theory is a body of ideas, mathematical models, and methods 
directed to predict, estimate, understand, and optimize the lifespan 
distribution of systems and their components (adapted from Barlow & 
Proschan 1965). The theory explains why the age-related increase in 
mortality rates declines at older ages.  
 
The Reliability theory seems to be a promising approach for developing a 
comprehensive biodemographic theory of ageing and longevity integrating 
mathematical methods with specific biological knowledge.  
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1.3. A chronology of the earliest and recent models of old age 
mortality 
   
In the distant past, the age pattern of mortality of the oldest old (80 years 
old and over) was not well-known. Knowledge of mortality among persons 
approaching the age of 100 (or more), in particular, was mainly based on 
unreliable statistics and theoretical concepts. In recent decades, this 
situation has gradually changed. Efforts have been made to improve past 
as well as recent mortality statistics and to develop methods of estimating 
mortality age patterns in cases where data are inaccurate. The reason that 
underlies these new developments is quite simple. As a result of a 50-year 
persistent decline in mortality, the number of persons surviving to very old 
ages has increased dramatically. As a result, institutions involved in social 
policies that strive to balance the needs of, and resources for the elderly, 
have become interested in reliable and detailed population projections. 
 
Although Chapter Three provides more in depth information on how old 
age mortality is estimated , below is a brief historical review of the most 
important mathematical models that have been developed to describe and 
explain human mortality, starting with the first detailed investigation of 
mortality by Graunt (1661). 
 
• In 1661 Graunt carries out the first detailed investigation of 
mortality of Londoners (“Natural and Political Observations made 
upon the Bills of Mortality”). 
 
• In 1693 Edmond Halley published an article with following title in 
the Philosophical Transactions of the Royal Society of London: “An 
Estimate of the Degrees of the Mortality of Mankind, drawn from 
curious Tables of the Births and Funerals at the City of Breslaw; with 
an attempt to ascertain the Price of Annuities upon Lives” .This 
important work contains the first ever known mortality table and had 
a fundamental influence on mortality statistics and on social 
statistics in general. 
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• In 1725 De Moivre published “Annuities on Lives” where proposed 
a piecewise linear survivor function S(x)-S(x+t)=a t assuming that 
the probability of remaining alive decreased with age in an 
arithmetic progression.  
 
• In 1746 Deparcieux used a life table method to show increases in 
life expectancies and his results were published in the 1746 treatise 
‘Essai sur les probabilités de la durée de la vie humaine’.  
 
• In 1766 Bernoulli first studies the properties of mortality intensity 
µ(x).  
 
• In 1772 Lambert calls the inverse of this the ‘force of vitality’ and 
develops the earliest mathematical models for the survivor function 
S (x). He was the first expresses the gradual ‘exhaustion of man’s 
power’ in a mathematical formula. 
 
• In 1798 Malthus predicted the exponential increase of human 
population as a consequence of the misery and famine that was 
suffered at the time unless family size was regulated. The model 
was later adjusted by Verhulst in 1838, to limit the population 
growth predictions. 
 
• In 1825 Benjamin Gompertz proposed the first explanatory 
model, and the most influential parametric mortality model in the 
literature. He recognised that an exponential pattern in age captured 
the behaviour of human mortality for large portions of the life table. 
Later was found that at advanced ages mortality rates increase less 
rapidly than an exponential function. However, the close fit of the 
Gompertz function to empirical data suggested that a "law of 
mortality" may exist to explain the age patterns at death for 
individuals and populations.  
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• In 1860 Makeham noticed that the Gompertz equation failed to 
capture the behaviour of mortality at higher ages and added a 
constant term in order to correct for this deficiency. The constant 
can be thought of representing the risk of death by causes that are 
independent of age.  
 
     •    In 1871 Thiele develops the first complex model that attempts to    
           accurately model m(x) over the whole life span. 
 
 
1.4. Financial implications of the Ageing Population 
 
Population in developed countries is aging rapidly. Both the number and 
proportion of people aged 65 years and older are increasing, although at 
different rates in different parts of the world. Figure 1 shows that the age-
dependency ratio3 will increase by around ¼ over to 2050, this change in 
the age-dependency ratio will be the result of the population trend. For 
example, Europe has the highest proportion of elderly and will probably 
remain the oldest region for decades, while Japan is the only non-European 
country with a similar ageing population as the European countries. As part 
of the same process, the older population itself will age, with large 
increases in the number of people aged 85 and older. As a consequence, 
the number of oldest-old persons in developed countries is increasing at a 
much faster rate than any other age group. This also means that the 
proportion of the population that is very old will rise, which will place 
increased financial pressure on the social security system.        
            
                                                 
3 Age-dependency ratios are a measure of the age structure of the population. They relate the number 
of individuals that are likely to be “dependent” on the support of others for their daily living – youths 
and the elderly – to the number of those individuals who are capable of providing such support. The 
key indicator of age dependency used relates the number of individuals aged less than 20 and of those 
aged 65 and over to the population aged 20 to 64. 
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                        Source: OECD Demographic and Labour Force database                
 
 
Under pay-as-you-go4 social security systems most developed countries 
have made promises they can’t keep, as in their current forms they are not 
financially sustainable, while some already face financial crises. For 
example, member countries of the Organization for Economic Cooperation 
and Development5 are projected to experience a roughly 50% increase in 
the share of GDP that is devoted to old age pension expenditures over the 
next fifty years, from 7.4% of GDP to 10.8% of GDP (Thai-Thanh, Pablo & 
Howard 2001).  
 
It has been commonly assumed that the aging population is the main 
cause of the financial constraints for current, as well as future, old age 
pension schemes. The number of older persons is increasing very rapidly 
relative to the number of younger persons, a trend which will continue as 
was shown earlier in Figure 1. As a result, the proportion of retirees has 
                                                 
4 PAYG systems collect contributions on workers through a tax bearing on labour earnings and share 
the collected amount among the retirees in function of their past contributions according to some fixed 
benefit rule (for instance, it is shared in proportion to individuals’ contribution)(Gabrielle Demange 
(2006)) 
5 The OECD member countries are: Australia, Austria, Belgium, Canada, Czech Republic, Denmark, 
Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Korea, Luxembourg, 
Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Slovak Republic, Spain, Sweden, 
Switzerland, Turkey, United Kingdom, United States. 
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increased relative to the number of employed persons who must pay for 
the benefits of those who are retired. In addition, persons are living longer 
so that those who reach retirement age are receiving benefits longer than 
they used to. 
 
 
1.5. Structure of the PhD Research Report (tesina) 
 
The tesina includes five chapters, starting with an introduction to the topic 
(Chapter 1). This is followed by a theoretical background on old age 
mortality (Chapter 2) that reviews concepts and modern theories of 
mortality. I then address strictly empirical considerations related to the 
estimation of old age mortality (Chapter 3). In Chapter 4 I try to 
incorporate Biodemography into the modelling of old age mortality and the 
final part intents to synthesize the earlier chapters and discuss its 
usefulness for the proposed thesis (Chapter 5).  
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CHAPTER 2  THEORETICAL BACKGROUND TO OLD AGE MORTALITY6         
           
2.1. Introduction 
 
It is a fact of life that some people die in childhood, some during their adult 
years, and others in old age. Obviously, age at death is variable in all 
human populations, although the extent of this variability changes over 
time and differs across societies, and does so for a variety of reasons. 
Today in the more developed countries (e.g. Japan, France and 
Switzerland) life expectancy at birth continues to increase by three months 
every year although infant mortality does not exceed five per 1000 and 
which cannot decline much further. Instead, this increase of life expectancy 
is caused by adult mortality, in particular old age mortality. Mortality of old 
and even very old people is falling drastically, and paradoxically, this fall in 
itself has not been studied greatly beyond statistical descriptions, and little 
is still known of its causes and mechanisms (Catalano 2002; Myers 1996; 
Manton & Vaupel 1995; Wilmoth 1995; Kannisto et al. 1994; Vaupel & 
Lundstrom 1994; Horiuchi 1991; Kannisto 1988).  
In this part I examine the decline in old people’s mortality by cause of 
death within the context of the epidemiological transition theory, the 
variability of mortality in terms of the distribution of ages at death 
(rectangularization of survival curve and the compression of mortality) and 
                                                 
6 Julio Frenk (1997): “Transiciones: vidas, instituciones, ideas”. Conferencia Magistral "José Luis 
Bobadilla" dictada en el VII Congreso Nacional de Investigación en Salud Pública, conmemorativo del X 
Aniversario del Instituto Nacional de Salud Pública y del LXXV Aniversario de la Escuela de Salud 
Pública de México; 1997 marzo 4; Cuernavaca, Morelos. 
“The life is not but one sucesion of transitions. In them the deep processes of change are expressed 
that are leading of an existence stage to another one. The same it is applied to the people. In both 
cases the nico that it does not change, is the same change” 
“La vida no es sino una sucesión de transiciones. En ellas se 
expresan los procesos profundos de cambio que van 
conduciendo de un estadio de existencia a otro. Lo mismo se 
aplica a las personas. En ambos casos lo único que no cambia, 
es el cambio mismo”  
                         Julio Frenk6 
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the modern theories of mortality (evolutionary theory of senescence, 
reliability theory of ageing, and biodemography). 
Several interesting questions are related to this part. For example, Why did 
the recent transition in mortality took place? How long can it continue and 
what factors might contribute to future gains in life expectancy? How has 
the variability of age at death changed historically? What relationships, if 
any, exist between the level and the variability of human mortality? Can 
we assume that sometime in the future everyone has the potential to die 
from senescence related mortality? If so, are biological limits in the 
variability of human mortality related to limits in its level?  
 
 
2.2. The Epidemiological Transition Theory 
 
The impressive increase in length of life has been accompanied by 
substantial changes in the age at death and cause of death patterns. These 
shifts in age and cause–specific mortality are described by the 
Epidemiological Transition Theory that establishes a general framework of 
the description and interpretation of changes in the patterns of mortality 
and health during the decline of mortality, and its determinants and 
consequences (Omran 1971).  
 
According to Omran (1971), the epidemiological transition is a shift from 
the predominance of infectious diseases to degenerative disease and 
coincides with the mortality component of the (first) Demographic 
Transition Theory7. During the epidemiological transition the most profound 
changes in health and disease patterns occur among children and young 
women. Omran distinguished three stages: 
                                                 
7 The demographic transition theory explains how changes in mortality and fertility influences 
population growth. The basic demographic transition model describes the process during which slow 
population growth gives way to a period of rapid population growth, before reverting back to slow 
growth (Notestein et al., 1944). There is a fifth stage to the demographic transition. When fertility falls 
to very low levels and stays there for a protracted period, a slow rate of population growth can turn 
into a negative one. Many countries in Europe now have TFRs below the replacement level of about two 
children per woman. In the late 1990s, the TFRs of Bulgaria, Italy, Spain, the Czech Republic, Latvia 
and Russia- all 1.2 – were among the world’s (Haupt, A. 2004). Lesthaeghe and Van de Kaa (1986) in 
their introductory paper to Bevolking:groei en Krimp considered for the first time a Second 
Demographic Transition ( or Fifht Stage to the demographic transition. 
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1. “The Age of Pestilence and Famine” lasted until the middle of the 19th 
century, was characterized by high and fluctuating mortality and its 
peaks coincided with the years of epidemics, famine, crop failure, 
disasters and wars. A continuous population growth was impossible. 
In this stage the average life expectancy at birth was low and 
variable, oscillating between 20 and 40 years, while infant mortality 
exceeded 200 deaths per 1000 live births. An early epidemiological 
study based on the Bill of Mortality in 17th century London, reported 
that 3/4ths of death were attributed to infectious diseases, 
malnutrition and maternal complications. In contrast, heart diseases 
and cancer were responsible for less than 6% of deaths (United 
Nations. World Population Prospects, 1966 Revision. New York, United 
Nations, 1998). 
 
2. “The Age of Receding Pandemics” ended in the middle of the 20th 
century for most developed countries which was distinguished by the 
onset of the shift from infectious to chronic diseases. The average life 
expectancy at birth increased substantially from about 30 to 50 years, 
while infant mortality declined gradually to below 200/1000 live 
births. Population growth was sustained and began to describe an 
exponential curve. Communicable diseases (especially tuberculosis) 
continued to lead the causes of death. Towards the end of the second 
stage however, heart diseases, stroke and cancer started to take 
higher positions. Mortality from tuberculosis began to decline towards 
the end of this stage and was responsible for part of the decline in 
general mortality.  
 
3. ‘The Age of Degenerative and Man-made Diseases’ is characterized by 
the stabilization of mortality at a low level. Life expectancy at birth 
rose gradually from about 50 to 75 years or more, one began to 
observe a relative ageing of the population. In terms of specific 
diseases, characteristic of this stage was the increasing prevalence of 
heart diseases, cerebrovascular accidents (strokes), cancer at various 
sites, diabetes, chronic obstructive, pulmonary disease and metabolic 
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disorders, as well as those introduced by man (so-called man-made 
diseases). These include, for instance, diseases or external cause 
mortality related to radiation, industrial hazards, traffic accidents. 
Stress-related diseases such as depression and other mental illness, 
violence and drug dependency also increased. Although conceding 
their leading position, infectious diseases and gross malnutrition 
continued to be important causes of morbidity and mortality. 
 
Omran’s third stage marked the end of the epidemiological transition, with 
an end to the mortality decline. However, shortly afterwards, it was 
observed that mortality continued to decline throughout the 1970s in 
developed countries and for women this decline actually never completely 
stopped. In light of this, Olshansky and Ault (1986) proposed a fourth 
stage for the epidemiological transition in which mortality fell because the 
onset of and eventual mortality from chronic diseases was delayed to older 
ages.  
 
S. J. Olshansky and B. Ault (1986) were the first ones to propose a 
fourth stage after observing an uninterrupted increase in life expectancy. 
They thought this trend was significant enough to distinguish it from 
Omran’s three previous stages. This fourth stage is referred to as the “age 
of delayed degenerative diseases”, since the probability of death from 
these causes is shifted toward older ages, and it is summarized by three 
general characteristics: 
 
1. Rapidly declining death rates that are concentrated mostly in 
advanced ages and which occur at nearly the same pace for males 
and females.  
 
2. The age pattern of mortality by cause remains largely the same as in 
the third stage, but the age distribution of deaths for degenerative 
causes is shifted progressively toward older ages. 
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3. Relatively rapid movements in survival are concentrated among the 
population in advanced ages. 
Rogers and Hackenberg (1987) also put forward a fourth stage of the 
epidemiological transition. They agree with Olshansky and Ault that the 
major causes of death are still due to degenerative and man-made 
diseases, each is becoming increasingly influenced by individual behaviours 
and new life-styles, influences not concretely addressed in the present 
theory. The point they stress the most is the fact that Omran did not 
include violent deaths in his theory, or deaths due to social pathologies 
(such as accidents, suicides and homicides).  
In an article published in 1998, Omran recognizes the existence of one 
and possibly two additional stages to his initial epidemiological transition 
theory. According to him, the fourth stage that he called the “age of 
declining cardiovascular mortality, ageing, lifestyles modification, emerging 
and resurgent diseases”, is characterized by an ongoing rise in life 
expectancy until it reaches 80  to 85 years or longer, especially for 
females; by a stabilization followed by a decrease of cardiovascular 
diseases as a cause of death; as well as by the emergence of new diseases 
(HIV, Hepatitis B and C, Ebola, Lyme disease, Hantaan virus, New forms of 
E.Coli, etc.) and by the revival of former diseases (Cholera, Malaria, 
Dengue, Diphtheria, Tuberculosis, Plague and Chagas disease). The Fifth 
stage, the “Age of aspired quality of life with paradoxical longevity and 
persistent inequities” for the mid-21st century and beyond, is expected to 
be one of great human achievements in disease control, health promotion, 
and further prolongation of healthy life. Inevitably this stage will include, 
paradoxically, longevity and the emergence of new morbidity and 
persistent inadequacies. There will be disparities between people because 
of the polarization of socio-economic status within and between countries 
(Omran 1998).  
 
Robine (2001b) is even more austere than the previous researchers on his 
critique of the epidemiological transition theory. After studying the trend in 
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the dispersion of life spans Robine doubted of the existence of the last two 
stages of the theory (Omran’s third stage and Olshansky and Ault’s fourth 
stage) and he provided support for the existence of only three stages:  
 
1. The mythical reference era that precedes the fall in mortality, i.e. 
Omran’s “Age of Pestilence and Famine”, that came to an end 
between the 18th and 19th centuries depending on the country. 
 
2. A first stage of transition, when the level of mortality fell and tended 
to stabilize as a consequence of the decline in infectious diseases, in 
particular those affecting women and children, resulting in a very 
large reduction in the disparities of life spans. This “Age of Receding 
Pandemics” came to an end in the 1950s in the countries which had 
gone furthest in the transition, such as Northern and Western Europe, 
North America and Japan. 
 
3. A subsequent transition in which the mortality decline at adult ages, 
including among the very old, becomes relatively larger than at young 
ages and where the increase in life expectancy is no longer associated 
with a reduction in the dispersion of life spans - or with only a very 
small reduction. This new age corresponds less to Omran's third stage 
- which today appears to have little basis in reality - and more to the 
fourth stage proposed by Olshansky and Ault. Robine labelled this 
new stage as the "Age of the Conquest of the Extent of Life". This 
may be the age when man, having been finally liberated from the 
great epidemics, is able to explore the full extent of his life.  
 
Robine says that there is no doubt that this stage will come to an end one 
day due to the start of a new stage that he labelled as the "Age of Limits", 
even though at present man is making unexpected discoveries in its 
exploration of the potential of human longevity, whereby some consider 
that it may be possible to live for between 110 and 120 years (Robine 
2001b). 
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As for Meslé and Vallin (2002), they revised the Epidemiological theory 
into two stages only. They consider Omran’s first three stages, during 
which the improvement in survival is mostly due to the collapse of 
infectious diseases and the rise of chronic diseases, as just one stage. The 
end of this first stage would lead directly to the decline of cardiovascular 
diseases, which would be the main factor underlying the growth of life 
expectancy during the second stage. They refer to this stage as the 
“cardiovascular revolution”. 
 
Most of the declines in mortality and gains in life expectancy during this 
recent mortality transition have been achieved in the elderly population- a 
phenomenon so unexpected and unexplained that it has been referred to 
as a new stage in the epidemiologic history of developed nations. 
Consequently, this emergence of ninety-year old and centenarian 
populations throws a new doubt on the now traditional theory of 
epidemiological transition and its explanations. A theory that explains how 
we reached the current stage still remains to be found, with age-specific 
mortality trends, the emergence of the oldest-old, factors determining their 
states of health, in particular their functional state, and the causes of their 
death. Thus, a theory that can be used to improve forecasts for the future 
still remains to be found. Where do the current transitions lead us? 
 
 
2.3. Variability of mortality in terms of the distribution of ages at      
death 
 
Biologists were the first to become interested in the shapes and 
transformation of the survival curve, long before demographers showed 
any concern (Comfort (1956, 1964); Deevey 1947; Pearl & Miner 1935; 
Greenwood 1928; Pearl & Doering 1923). At this time demographers were 
undoubtedly more interested in fertility and in the fall of infant mortality 
than in life durations and population ageing. In 1964 Comfort introduced 
the concept of the rectangularization of the survival curve, and the concept 
was subsequently discussed by others (Gordon 1980; Vaupel et al. 1979; 
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Strehler 1975). In 1980 James Fries popularized the concept by publishing 
his theory on the compression of morbidity in the New England Journal of 
Medicine. Drawing on the work of the biologist Comfort (1964), Fries 
observed that the historical increase in life expectancy was accompanied 
by a gradual "rectangularization" of the survival curve. He argued that this 
change was responsible for a shift to an "ideal" survival curve, highly 
rectangularized, corresponding to a life expectancy at birth of 85 years and 
with a high concentration of individual life spans around this average 
value: 66% of life spans would be between 81 and 89 years and 95% 
between 77 and 93 years. Fries justified this prediction by the existence of 
a fixed biological maximum limiting the human life span to roughly 100 
years and the average life span to 85 years. After that, the 
rectangularization of the survival curve appeared in the heated debates 
followed for demographers (Fries (2002, 1989, 1984); Olshansky et al. 
1991; Rothenberg et al. 1991; Myers & Manton 1984; Schneider & Brody 
1983). 
 
This part of the research analyzes the change of the variability in the age 
at death and in the life expectancy to evaluate the rectangularization of 
survival curve. Thus, there is a review of different discourses about 
whether mortality is becoming more or less compressed at present, if there 
is or not a limit of human life span and when rectangularizat¡on has or has 
not occurred. 
 
 
2.3.1. Compression of mortality 
 
Since 1980 researchers have questioned whether mortality compression is 
occurring (e.g., Fries 1980, 1984), where compression generally refers to 
the diminishing of the variance in the distribution of age at death over 
time. This question is now more than 20 years old, and evidence exists 
both for and against compression (Lynch & Brown 2001; Kannisto  2000b; 
Nusselder & Mackenbach 1996; Manton & Singer 1994; Olshansky & 
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Carnes 1994; Carnes & Olshansky 1993 Manton & Tolley 1991; 
Rothenberg, Lentzner & Parker 1991;Olshansky, Carnes & Cassel 1990). 
 
Regarding the history of mortality compression, there is existing evidence 
sufficient for proving that the transition from high to low mortality- and, 
thereby, to modern society- has been accompanied by general and 
massive compression of the mortality to ever narrower age intervals.  
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                Source: Data available through the Berkeley Mortality Data Base.  
                                 http:// demog.berkeley.edu      
 
Figure 2 shows the distribution of the age at death of Swedish males 
before and after the mortality transition and we can see that the 
compression of mortality actually includes two separate processes. On one 
hand, the lives saved through the progressive elimination of premature 
deaths have been redistributed to older ages and this has been the motor 
of the compression of mortality throughout most of the transition. On the 
other hand, as people survive to ever higher ages, they enter an area 
where the lengthening of life meets increasing resistance, demonstrated by 
the fact that the decline in old age mortality in recent decades has been 
very much faster near age 80 than 100 (Kannisto 1996). 
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The decline of human mortality during the industrial era is typically 
described in terms of increased life expectancy or decreased risks of death 
across the age range. In contrast, the decreased variability of age at death 
has received relatively little attention. Similarly, although some studies 
have been conducted on social and behavioural effects of the historical 
mortality decline (e.g. several articles in United Nations 1986), little 
research has focused on the consequences of reduced variability in age at 
death. Indeed, most analyses of the compression of mortality have been 
motivated by questions about biological limits to the human life span, with 
little discussion of the broader historical significance of this phenomenon. 
 
Finally, long-term changes in the variability of age at death may have had 
significant effects on perceptions, attitudes, and behaviours of individuals 
and, in turn, on society in general. What should we expect about future 
trends in the variability of age at death in low mortality populations? If the 
current decline in mortality ceases, the distribution of ages at death 
(including levels of variability) will stabilize. Yet if mortality rates continue 
to decline rapidly at both younger and older adult ages, we should expect a 
continuing pattern of stability in the variability of ages at death, as the 
entire distribution shifts upward. These broad consequences of the 
historical compression of mortality merit a more fully detailed analysis. 
 
 
2.3.2. Limit of human life span8 
 
Estimates of limits to human life span (defined as the “biologically” 
maximum length of life) and of population life expectancy are made by 
demographers, biologist and actuaries. Despite the significance of a life 
expectancy limit for private and public pension programs and for private 
and public short and long-term health insurance, there is little consensus 
                                                 
8 One of the earliest suggestions that the human life span is fixed appears in the Old Testament: “ My 
spirit hill not abide in man forever, for he is mortal; his days will be a hundred and twenty years” ( 
Genesis 6:3) 
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on the value at which the limit is set (or if a limit should be considered at 
all). 
 
Perspectives on the issue can be roughly divided into three groups: 
 
1. The “traditionalists”: they suggest that the limit is not significantly 
greater than current life expectancy, namely about 85 years (Fries 
1990; Olshansky, Carnes & Cassel 1990 ;).The limit is viewed as being 
due to biological senescence, which is not affected by the changing 
patterns in mortality by specific causes. 
 
2. The “visionary”: they argue that, while life expectancy limits are due to 
senescence, advances in biomedical research will raise those limits in 
the future (in some 25 to 50 years). Since senescence itself is thereby 
modified, life expectancies of 100 to 125 years (Strehler 1975) or more 
150 to 200 years, (Walford 1985; Rosenberg et al. 1973) might be 
achievable. It is suggested that altering senescence has implications for 
age-dependent diseases (Strehler 1975). 
 
3. The “empiricist”: they contend that we are not currently near a life 
expectancy limit, because mortality is declining and progress is being 
made in the treatment and management of the chronic diseases and 
disabilities that dominate mortality at later ages. It is observed that, if 
recent mortality declines of about 2 percent per year are continued, life 
expectancies of 95 to 100 years could be achieved by the year 2080 
(Ahlburg & Vaupel 1990; Schneider & Guralnik 1990; Guralnik, 
Yanagishita & Schneider 1988; Schneider & Guralnik 1987).  
 
In spite of many attempts, an absolute limit to human life has never been 
conclusively proven, and recent extensive studies of the very oldest have 
not found evidence of any limit (Vaupel 2004; Thatcher et al.1998). 
Nevertheless, as the probability of dying keeps rising in modern 
populations to at least the age of 110, it reduces the dispersion 
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progressively. In the words of Keyfitz (Keyfitz 1978), there is “an uphill 
road ahead” for extending human life. 
 
 
2.3.3. Rectangularization of human survival curve 
 
Rectangularization is defined as a trend towards a more rectangular shape 
of the survival curve due an increase of survivals to advanced ages, an 
upper boundary to human life expectancy determined by fixed genetic 
limits and to an increase of the concentration of deaths around the mean 
age at death of the population (Nusselder 1998). That is, the variability in 
the age at death declines and deaths are being compressed into the upper 
years of life.  
 
This rectangularity of the survival curve is visible in Figure 3, which shows 
changes in the survival curve for the population of the Sweden in 1900 and 
1995 and illustrates how the survival curve has become more rectangular 
as more individuals survive through childhood and young adulthood, but 
then die off rapidly in old age.        
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More than 20 years after Fries's (1980) reintroduction of the concept, there 
appears to be no consensus on a definition of this phenomenon and of how 
to assess it in a continued debate on the rectangularitzation of the survival 
curve ( Martel & Bourbeau 2003; Fries (2002,1989,1984); Cheung 2001; 
Yashin et al. 2001; Coale 1996; Manton & Stallard 1996; Eakin & Witten 
1995; Manton & Singer 1994; Manton & Tolley 1991; Olshansky et al. 
1991; Rothenberg et al. 1991; Myers & Manton 1984; Schneider & Brody 
1983). Many demographers who have studied the transformation of 
survival curves in different countries have found evidence of 
rectangularization during the epidemiological transition and they agree 
with Fries that rectangularization has been an important characteristic of 
historical mortality change in humans, although sometimes they observe 
that rectangularization has become slower in recent decades (Martel & 
Bourbeau 2003; Cheung 2001; Robine 2001a; Wilmoth & Horiuchi 1999; 
Paccaud et al. 1998; Nagnur 1997, 1986; Pelletier et al. 1997 Levy 1996; 
Manton & Stallard 1996; Nusselder & Mackenbach 1996; Eakin & Witten 
1995; Go et al. 1995; Hill 1993; Rothenberg et al. 1991). 
  
Others suggest that the concept of rectangularization has been poorly 
defined and subjectively judged in visual terms on occasion. For example, 
Manton & Tolley (1991) proposed distinguishing between "hard" and "soft" 
rectangularization to distinguish the degree of rectangularization. Coale 
(1996) described the survival curve in low-mortality populations as being 
nearly flat from age 5 to 55, then starting to fall, later becoming steeper, 
and even following a vertical fall as an innate maximum age is approached. 
And for others rectangularitzation of the survival curve is “a myth” (Myers 
& Manton (1984)) or an “ill-posed question” (Manton & Tolley 1991), or 
even that mortality is now undergoing an expansion, rather than a 
compression, at the oldest ages (Rothenberg, Lentzner & Parker 1991).  
                      
The literature also shows little agreement about how to measure 
rectangularity and variability. Fries and other early researchers depended 
essentially on visual inspection. Since that time, several different measures 
 32 
have been used (Nusselder & Mackenbach 1996; Eakin & Witten 1995; 
Myers & Manton 1984), but no systematic effort has been made to list and 
compare the various possible measures. 
 
 
2.4. Biodemographic theories of mortality 
 
Research on human mortality, particularly in the field of ageing, has 
become an important part of biodemographic studies because of a growing 
interest in the scientific explanations of ageing and in the search for a 
general theory that can explain what ageing is and why and how it 
happens (Carey & Judge 2001). 
 
In particular, many researchers consider that a comprehensive 
biodemographic theory of species ageing and longevity should provide 
answers to a number of important questions (Gavrilov &  Gavrilova 2001) 
that include: 
 
• Why do most biological species deteriorate with age (i.e., die more 
often as they grow older) while some primitive organisms do not 
demonstrate such a clear age dependence for mortality increase? 
(Haranghy & Balázs 1980; Finch 1990; Martinez1998). 
 
• Specifically, why do mortality rates increase exponentially 
(Gompertz law) with age in many biological species? (Strehler 1978; 
Finch 1990) How should we handle cases when the Gompertzian 
mortality law is not applicable? (reviews in Strehler 1978). 
 
• Why does the age-related increase in mortality rates disappear at 
older ages? Why do mortality rates eventually decelerate when 
compared to predictions of the Gompertz law, occasionally 
demonstrate leveling-off (late-life mortality plateau), or may even 
show a paradoxical decrease at extreme ages? (Gavrilov & Gavrilova 
2002b). 
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• How do we explain the so-called compensation law of mortality? 
(Gavrilov & Gavrilova 1991). The Compensation law of mortality 
(late-life mortality convergence) states that the relative differences 
in death rates between different populations of the same biological 
species are decreasing with age, because the higher initial death 
rates are compensated by lower pace of their increase with age. 
 
According to Gavrilov & Gavrilova (2001), the search for a general 
biological theory to explain such questions on ageing and longevity has 
been made mainly in terms of two theories: 
 
1.-Evolutionary Theory of Ageing: Important advocates and 
contributors to evolutionary theory of ageing include: Le Bourg 
(1998,2001); Keller & Genoud (1999,1997); Kirkwood (1999, 
1993); Charlesworth 1994;Carnes & Olshansky 1993; Rose 1991; 
Hamilton 1966; Williams 1957; Medawar (1951, 1946); Weismann 
1882.  
 
2.-Reliability Theory of Ageing: The most important contributions to 
reliability theory of ageing are coming from Lloyd & Lipow 1962; 
Barlow & Proshan 1975; Barlow, Proschan & Hunter 1965, Kaufmann 
et al. 1977; Crowder et al. 1991; Aven & Jensen 1999; Rigdon & 
Basu 2000. This theory allows researchers to understand many 
puzzling features of mortality and lifespan (Bains 2000; Gavrilov & 
Gavrilova (2001, 1993, 1991); Gavrilov (1987, 1978); Doubal 1982; 
Abernethy 1979; Gavrilov et al. 1978). 
 
The purpose of this part is to review the literature within the field of ageing 
with a balanced scientific discussion of the evolutionary theories of ageing 
and the relative theory of ageing.  
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2.4.1. Evolutionary theory of ageing9 
 
According to Weismann (1882), Medawar (1951) and Williams (1957) the 
classic evolutionary theory of ageing seeks to explain why mortality rises 
with age as health and function decline. In this theory, as individual age, 
their continued survival contributes less and less to reproductive fitness, 
because less of their lifetime fertility remains. Consequently, natural 
selection acts more weakly to reduce mortality at older ages. Although this 
theory has been extended and qualified, it is still the dominant paradigm 
for the evolution of senescence (Rose 1991). 
 
The following three major evolutionary theories of ageing are discussed:  
 
1.-  The Theory of Programmed Death. 
 
This theory was suggested by August Weismann (1882), one of the first 
biologists to use evolutionary arguments to explain ageing and one of the 
forerunners of the evolutionary theory of ageing, argued that "there is no 
reason to expect life to be prolonged beyond the reproductive period; so 
that the end of this period is usually more or less coincident with death" 
(quoted in Rose, 1991). 
 
His initial idea was that there exists a specific death-mechanism designed 
by natural selection to eliminate the old, and therefore worn-out, members 
of a population (Weismann 1882). The purpose of this programmed death 
of the old is to clean up the living space and to free up resources for 
younger generations10.   
                                                 
9Biologists suggest the evolutionary theory of aging as “the intellectual core of gerontology” (Rose 
1991). The evolutionary theory of aging may be considered as part of a more general life history theory 
Stearns 1992). The evolutionary theory of aging is considered to be the intellectual core of the 
biodemography of aging and longevity (Carnes & Olshansky 1993). The evolutionary theory of aging is 
a subset of the life history theory (Le Bourg 2001). 
 
10 Weismann probably came to this idea while reading the following notes of Alfred Russell Wallace (one 
of Darwin's contemporaries and a codiscoverer of natural selection), which he later cited in his essay 
“The Duration of Life” (1889): “…when one or more individuals have provided a sufficient number of 
successors they themselves, as consumers of nourishment in a constantly increasing degree, are an 
injury to those successors. Natural selection therefore weeds them out, and in many cases favours 
such races as die almost immediately after they have left successors.” 
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While discussing Weismann's evolutionary theory of ageing, it is important 
to know that his scientific views evolved significantly over the course of his 
life. Later Weismann stopped writing about the “injuriousness” of the old 
and changed his evolutionary views, considering old organisms not as 
harmful but simply neutral for the biological species: 
 
 “…in regulating duration of life, the advantage to the species, and 
not to the individual, is alone of any importance. This must be obvious to 
any one who has once thoroughly thought out the process of natural 
selection. It is of no importance to the species whether the individual lives 
longer or shorter, but it is of importance that the individual should be 
enabled to do its work towards the maintenance of the species.…The 
unlimited existence of individuals would be a luxury without any 
corresponding advantage” (Weismann 1892). 
   
But he did not receive as much attention as his famous earlier theory of 
programmed death. After his death in 1914, his name became forever 
associated with the earlier, not the later, version of his theory11.  
 
2.- The Mutation Accumulation Theory of Ageing  
 
This evolutionary theory, suggested by Peter Medawar (1946) considers 
ageing as a product of natural selection. For example, a mutant gene that 
kills young children will be strongly selected against (will not be passed to 
the next generation) while a lethal mutation with effects confined to people 
over the age of 80 will experience no selection because people with this 
mutation will have already passed it to their offspring by that age. Over 
successive generations, late-acting deleterious mutations will accumulate, 
leading to an increase in mortality rates late in life.  
                                                                                                                                             
 
11 This can be seen in the 1922 edition of the book The Biology of Death written by Raymond Pearl: “In 
his famous address of 1881 on the duration of life, Weisman propounded the thesis that death was an 
adaptation, advantageous to the race, and had arisen and was preserved by natural selection. Probably 
no more perverse extension of the theory of natural selection than this was ever made” (p. 43) 
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According to this theory, persons loaded with a mutant gene have fewer 
chances to reproduce if the deleterious effect of this mutation is expressed 
earlier in life. By contrast, people expressing a mutation at older ages can 
reproduce before the illness occurs. In other words, the mutation 
accumulation theory predicts that the frequency of genetic diseases should 
increase at older ages.  
Obviously, the most important conceptual problems with the theory of the 
accumulation of mutations at old age are that it predicts that diseases are 
more common at old age than at young age, which is a mere tautology, 
and that the risk of dying increases with age. However, the fact that 
mortality rates can decelerate at old ages is a difference with the theory 
(Pletcher & Curtsinger 1998). 
 
If this theory is considered as the main or unique cause of ageing, it may 
be ruled out. By contrast, if one considers that it describes one cause of 
ageing among others, the theory may be valuable. Indeed, some features 
of ageing could be due to such alleles with a late expression while other 
ones could be best explained by different mechanisms. If the mutations at 
old age explain only a part of the ageing process, “plateaus far below 
100%” could be explained (Gavrilov & Gavrilova 2002). 
 
3.- The Antagonistic Pleiotropy Theory of Ageing  
 
The Antagonistic Pleiotropy Theory was proposed by George Williams 
(1957), who noticed that natural selection may be said to be biased in 
favour of youth over old age whenever a conflict of interests arises. 
According to him, this conflict arises from: 
 
“pleiotropic genes that have opposite effects on fitnesses at different 
ages.…Selection of a gene that confers an advantage at one age and a 
disadvantage at another will depend not only on the magnitudes of the 
effects themselves, but also on the times of the effects. An advantage 
during the period of maximum reproductive probability would increase the 
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total reproductive probability more than a proportionately similar 
disadvantage later on would decrease it. So natural selection will 
frequently maximize vigour in youth at the expense of vigour later on and 
thereby produce a declining vigour (ageing) during adult life”  (Williams 
1957).  
In other words, Williams suggested the existence of so-called pleiotropic 
genes (demonstrating favourable effects on fitness at young ages and 
deleterious ones at old age) that could explain the ageing process. Such 
genes will be maintained in the population due to their positive effect on 
reproduction at young ages despite their negative effects at old post-
reproductive age (their negative effects in later life will look exactly like the 
ageing process) (Gavrilov & Gavrilova 2002). 
Another prediction of the trade-offs between reproductive capacity and 
longevity was made by George Williams in the following way: “Successful 
selection for increased longevity should result in decreased vigour in 
youth” (Williams 1957).  
Since the 1960s, no fundamentally new evolutionary theories of ageing 
have been proposed. There were, however, attempts to find a better name 
for the antagonistic pleiotropy theory and to specify in more detail how one 
and the same gene could have both deleterious and beneficial effects. In 
particular, the disposable soma theory was proposed (Kirkwood & 
Holliday1979; Kirkwood 1977), which postulated a special class of gene 
mutations with the following antagonistic pleiotropic effects: these 
hypothetical mutations save energy for reproduction (positive effect) by 
partially dissabling molecular proofreading and other accuracy promoting 
devices in somatic cells (negative effect). The authors of the disposable 
soma theory argued that “it may be selectively advantageous for higher 
organisms to adopt an energy saving strategy of reduced accuracy in 
somatic cells to accelerate development and reproduction, but the 
consequence will be eventual deterioration and death” (Kirkwood & 
Holliday 1979).  
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When applied at the evolutionary level, the soma theory is not really 
different from the antagonistic pleiotropy theory. As emphasized by 
Kirkwood & Rose (1991), the disposable soma theory is a causal subset of 
the antagonistic pleiotropy theory. In fact, “the difference between the 
disposable soma theory and the antagonistic pleiotropy is partly a 
difference between an optimality approach… and a quantitative genetics 
approach”, but the two theories do not differ in their predictions regarding 
trade-offs between reproduction and longevity. 
 
These evolutionary theories offer a convincing explanation of the ageing 
process and the question now is to know whether they may be considered 
as validated or not. During the last twenty years, some gerontologists have 
tried to confirm or invalidate evolutionary theories of ageing12. We may 
wonder whether it is useful to spend the next twenty years to test them 
again, since it is clear that they explain, at least partly, the ageing process. 
These theories probably still need to be refined. New tests of them are 
surely useful. However, testing them is probably no longer a top priority. 
This priority could be to find new means to modulate the ageing process in 
animal models (worms, flies, rodents or primates), using genetic or 
environmental manipulations, to finally improve everyday life of elderly  
(Le  Bourg 2001). 
 
 
2.4.2. Reliability Theory of Ageing  
 
It looks like the evolutionary theory is more appropriate to explain early 
successes of biological species (e.g., reproductive success), rather than 
their later failures (ageing and death). Thus, there seems to be a missing 
piece in the theoretical body of evolutionary biologists trying to explain 
                                                 
12 In 1989, Rose and Graves wrote, “if other biologists could accept the sufficiency of the evolutionary 
theory as the general theory of ageing, then there might be a relaxation of efforts to find general 
physiological theories of ageing”. Keller and Genoud (1997) showed “that evolutionary theories of 
ageing are consistent with the high longevities of queens”.  In 2001, Le Bourg E conclude saying, “To 
be perfectly clear, the evolutionary theories give a plausible explanation of the aging process, but in 
many occasions they do not fit to the results: since better theories are not available, we could accept 
them provisionally”. 
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ageing, and this missing piece is about the general theory of system 
failures known as the theory of reliability.  
 
The Reliability Theory of Ageing is a body of ideas, mathematical models, 
and methods directed to predict, estimate, understand, and optimize the 
lifespan distribution of systems and their components (Barlow & Proschan 
1965).  
 
Reliability theory explains why most biological species deteriorate with age 
(i.e., die more often as they grow older) while some primitive organisms 
do not demonstrate such a clear age dependence for mortality increase. 
The theory predicts that even those systems that are entirely composed of 
non-ageing elements (with a constant failure rate) will nevertheless 
deteriorate with age, if these systems are redundant in irreplaceable 
elements. Ageing, therefore, is a direct consequence of systems 
redundancy. The 'apparent ageing rate' (the relative rate of age-related 
mortality acceleration corresponding to parameter in the Gompertz13 law) 
increases, according to reliability theory, with higher redundancy levels. 
Therefore, a negligible 'apparent ageing rate' in primitive organisms 
(Martinez 1998; Finch 1990; Haranghy & Balázs 1980) with little 
redundancy is a predicted observation for reliability theory (Gavrilov & 
Gavrilova 2002). 
 
The reliability theory explains why mortality rates increase exponentially 
with age in many adult species (Gompertz law) by taking into account the 
initial flaws (defects) in newly formed systems. It also explains why 
organisms 'prefer' to die according to the Gompertz law, while technical 
                                                 
13 Gompertz (1825) recognised that  an exponential pattern in age captured the behaviour of human 
mortality for large  portions of the life table. He proposed the function: µx = A cx  
Where A and c are constants. The left hand equation (1) is simply the definition of the force of 
mortality (μx,) as the instantaneous rate of mortality at age x. The right hand equation(1) is the actual 
‘law’. The constant A reflects the general level of mortality in the population concerned. The constant c 
(the Gompertz constant) reflects the rate at which the force of mortality increases with age. 
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devices usually fail according to the Weibull14 (power) law. Moreover, the 
theory provides a sound strategy for handling those cases when the 
Gompertzian mortality law is not applicable. In this case, the second best 
choice would be the Weibull law, which is also fundamentally grounded in 
reliability theory. Theoretical conditions are specified when organisms die 
according to the Weibull law: organisms should be relatively free of initial 
flaws and defects (Gavrilov & Gavrilova 2002). 
 
In those cases when none of these two mortality laws is appropriate, 
reliability theory offers a more general failure law that is applicable to adult 
and extreme old ages. The Gompertz and the Weibull laws are just special 
cases of this unifying more general law. 
 
Reliability theory also explains why the age-related increase in mortality 
rates vanishes at older ages. It predicts the late-life mortality deceleration 
with subsequent levelling off, as well as the late-life mortality plateaus, as 
an inevitable consequence of redundancy exhaustion at extreme old ages. 
This is a very general prediction of reliability theory: it holds true for 
systems built of elements connected in parallel, for hierarchical systems of 
serial blocks with parallel elements, for highly interconnected networks of 
elements (Bains 2000), and for systems with avalanche-like random 
failures (Gavrilov & Gavrilova 1991). 
 
The reliability theory also predicts that the late-life mortality plateaus will 
be observed at any level of initial damage: for initially ideal systems, for 
                                                 
14Weibull proposed a model in 1951 which represents the failure of a technical system due to wear and 
tear:µ(x)=A xθ 
If we consider the distribution of the times till failure of human organs, and suppose that death occurs 
when the first failure occurs, we have an analogy with mortality. A distinguishing feature of parametric 
hazard models is the assumption concerning the shape of the risk function. Rather than modelling the 
hazard function directly, one can model a function of the hazard which may be easier to estimate from 
empirical data. For example, the probability that an individual alive at age 0 will survive to age x can 
be written in terms of the hazard function:  X p= exp  - ∫  µ (s) ds  (Higgins T 2003)       
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highly redundant systems saturated with defects and for partially damaged 
redundant systems with an arbitrary number of initial defects. 
  
Furthermore, reliability theory predicts paradoxical mortality decline in late 
life (before eventual levelling-off to mortality plateau) if the system is 
redundant for non-identical components with different failure rates (Barlow 
& Proschan 1975; Barlow et al. 1965). Thus, in those cases when 'apparent 
rejuvenation' is observed (mortality decline among the oldest-old) there is 
no need to blame data quality or to postulate initial population 
heterogeneity and 'second breath' in centenarians. The late-life mortality 
decline is an inevitable consequence of age-induced population 
heterogeneity expected even among initially identical individuals, 
redundant in non-identical system components (Gavrilov & Gavrilova 
2001). Recently this general explanation was also supported using 
computer simulations (Bains 2000). Late-life mortality decline was 
observed in many studies (Khazaeli et al. 1995; Carey et al. 1992; Barrett 
1985) and stimulated interesting debates (Klemera & Doubal 1997; 
Olshansky 1998) because of the lack of reasonable explanation. Reliability 
theory predicts that the late-life mortality decline is an expected scenario 
of systems failure. 
 
The theory explains the compensation law of mortality, when the relative 
differences in mortality rates of compared populations (within a given 
species) decrease with age, and mortality convergence is observed due to 
the exhaustion of initial differences in redundancy levels (see Figure 4). 
 
Reliability theory also predicts that those experimental interventions that 
change 'true ageing rate' will also suppress mortality convergence, 
providing a useful approach on how to search for factors affecting ageing 
rate.  
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   Figure 4: Compensation law of mortality 
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   Graph 1: an example of fictitious human mortality from different populations. 
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                     Graph 2: an example of mortality of different fictitious species. 
 
 
2.5. Conclusions 
 
Causes of death form an integral part in the dynamic of the epidemiological 
transition, as each phase is typified by a particular cause-of-death 
structure. However, the transition from one phase to the net not only 
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signifies a change in mortality structure, it also implies a change in the 
prevalence and type of disease determinants. 
 
Findings obtained in this study do not provide straightforward arguments in 
favour or against the rectangularization of the survival curve in developed 
countries. On the one hand, several results are compatible with Fries’ 
theory. There is a sustained increase in age at death, with a shift in 
distribution toward the right hand side (Fig 3). And on the other hand, 
several results do not fit with any ongoing rectangularization.  
 
The three major evolutionary theories of ageing (The Theory of 
Programmed Death, The Mutation Accumulation Theory of Ageing, The 
Antagonistic Pleiotropy Theory of Ageing) offer a convincing explanation of 
the ageing process but the question now is to know whether they may be 
considered as validated or not. 
 
The reliability theory has an amazing predictive and explanatory power and 
requires only a few general and realistic assumptions. It offers a promising 
approach for developing a comprehensive theory of ageing and longevity 
that integrates mathematical methods with biological knowledge including 
cell biology (Abernethy 1998), evolutionary theory (Miller 1989; 
Charlesworth 1994) and systems repair principles (Rigdon & Basu 2000). I 
suggest, therefore, adding the reliability theory into the biodemographic 
methods to study aging and longevity. 
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CHAPTER 3  EMPIRICAL CONSIDERATIONS IN THE ESTIMATION OF  
OLD AGE  MORTALITY   15 
           
3.1. Introduction 
 
In the distant past, the age pattern of mortality of the oldest old (80 and 
over) was not well-known. Knowledge of mortality among persons 
approaching the age of 100 (or more), in particular, was mainly based on 
unreliable statistics and theoretical concepts. However, in recent decades 
this situation has gradually changed, as efforts have been made to improve 
past as well as recent mortality statistics and to develop methods of 
estimating mortality age patterns in cases where data are inaccurate. The 
reason underlying these new developments is quite simple. Due to a 50 
year persistent decline in mortality, the number of persons surviving to 
very old ages has increased dramatically. As a result, institutions involved 
in social policies that strive to balance the needs of, and resources for the 
elderly, have become interested in reliable and detailed population 
projections.   
 
The objective of this chapter is therefore to describe and comment on the 
most common forecasting models for old age mortality that have been 
used in developed countries. 
 
 
                                                 
15 Second Act of Medea by Lucio Anneo Séneca 
 “cleaving the waves with doubtful course, in weak tables it sails calm, while one is contiguous too 
much narrows separates the footpaths of life and death. … Now the seas feel won and accept the laws 
that the men dictate… Any log already crosses the abyss” 
“hendiendo las olas con dudoso rumbo, en débiles tablas navega tranquilo, 
mientras una linde demasiado estrecha separa las sendas de vida y muerte. 
… 
Ahora los mares se sienten vencidos y aceptan las leyes que dictan  los 
hombres 
… 
Ya cualquier barquilla recorre el abismo” 
                    Lucio Anneo Séneca15 
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3.2. Mathematical models of old-age mortality in developed  
          countries  
 
Most discussions about old-age mortality have focused on its trends, levels 
and age patterns. Two aspects are most often discussed: age patterns and 
trends in mortality at selected ages over time. It is a fact that age- specific 
death rates have declined over time, even at ages as high as 107-109 
years, the highest ages at the highest ages. However, there is little 
agreement among researchers with respect to the age patterns of old-age 
mortality. In this part I review the literature on Gompertz’s law of 
mortality, mortality trajectories with age, modelling of old age mortality by 
cause of death, and mortality models incorporating theoretical concepts of 
ageing. 
 
 
3.2.1. Age pattern of old age mortality: Gompertz’s law16 
 
Gompertz was an actuary who, like his contemporaries, was interested in 
the practical problem of estimating premiums for life annuities. But what 
separated Gompertz from the other actuaries of his time was that he saw 
the life table as more than just a working tool. He tried to go beyond the 
simple mathematics of insurance tables in an effort to understand why 
there were consistent age patterns of death among people. His motivation 
is perhaps best exemplified in a statement he made near the end of his 
career: "The object of research is not only to give information of facts, but 
to draw beneficial and general views; and if generalisations lead to 
probable theories, they should be regarded as pleasing associates, to be 
entertained at the feast of knowledge ..." (Gompertz (1872:330)). 
 
Here I review the literature on Gompertz's law of mortality and discuss the 
importance of his observations. The literature related to the Gompertz 
equation and his proposed law of mortality is extensive so I will mainly 
focus on an article by Olshansky & Carnes (1997) that I believe best 
                                                 
16 See Annex I and II for the main parameterization functions for mortality.  
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describes the important conceptual and methodological developments that 
have occurred since Gompertz's initial observations over 170 years ago. 
 
Gompertz published only three articles. In the first one, published in 1820, 
he identified a consistent rate of increase in death rates for some 
nineteenth century European populations for a limited portion of the age 
range. In his second one, published in the Transactions of the Royal 
Society (1825), Gompertz set what is now recognized as the law of 
mortality. After observing similar patterns of geometrical progression in 
other tables of mortality, Gompertz believed he had discovered a general 
law of mortality that linked arithmetic increases in age with geometric 
increases in death rates. He translated his finding about the law of 
geometrical progression into the conclusion that "if the law of mortality 
were accurately such that after a certain age the number of living 
corresponding to ages increasing in arithmetical progression, decreased in 
geometrical progression, it would follow that life annuities, for all ages 
beyond that period, were of equal value ..." (Gompertz (1825:515). From 
1825 to 1862 Gompertz was "engaged on the subject of what is called Vital 
Statistics" (Gompertz 1872:330) and published a paper in 1862 that 
focused primarily on revising his original notation. Gompertz presented a 
fourth article to the International Congress in 1860, but it was published 
after his death in the Journal of the Institute of Actuaries by his colleague, 
Dr.William Makeham (see Gompertz 1872). He noted that in his primary 
equation for geometric progression the parameters of his equation "were 
supposed to represent constant quantities, or at least were shown to differ 
very little from constants, for a very long term of years, for instance, about 
50 years…But in making the investigation, I did not pretend that [the 
parameters] were absolutely constant; were determined by a random 
selection from three distant periods of age, from a statement of the 
number of persons who will be living at different ages, out of a certain 
number of persons stated to have been born. And therefore as  Lx = A . Bqx 
will not perfectly, during the whole term of life, express the facts ..." 
(Gompertz 1872). 
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Olshansky & Carnes (1997) noted that Gompertz (1825:516) was 
somewhat vague on the issue of an age beyond which humans were 
incapable of living. At one point, he emphatically stated: "though the limit 
to the possible duration of life is a subject not likely ever to be determined, 
even should it exist, still it appears interesting to dwell on a consequence 
which would follow, should the mortality of old age be as described above. 
The non-appearance on the page of history of a single circumstance of a 
person having arrived at a certain limited age, would not be the least proof 
of a limit of the age of man; and further, that neither profane history nor 
modern experience could contradict the possibility of the great age of the 
patriarchs of the scripture." Later he qualified his position on a limit to life 
by stating: "Such a law of mortality would indeed make it appear that 
there was no positive limit to a person's age; but it would be easy, even in 
the case of the hypothesis, to show that a very limited age might be 
assumed to which it would be extremely improbable that any one should 
have been known to attain”. 
 
Moreover, as Olshansky & Carnes (1997) mention, Gompertz himself 
recognized that his original equation did not apply to the entire age range. 
In fact, Gompertz (1872) suggested in his last paper that there are four 
distinct periods in the life span between which separate laws of mortality 
apply: birth to 12 months, 12 months to 20 years, 20 years to 60 years, 
and 60 years to 100 years. His equation was intended to apply only to a 
limited age range for humans-between the ages of 20 and 60. Even within 
this age range he recognized that his formula worked best "provided the 
intervals be not greater than certain limits" (Gompertz (1825:514) quoted 
in Olshansky & Carnes (1997)). After that there has been a repeated 
historical recognition that a single Gompertz equation does not adequately 
describe mortality for humans over the entire life span. For example, 
Makeham (1867:346 in Olshansky & Carnes (1997) argued that even after 
he used his "partial forces of mortality" to characterize mortality schedules, 
the speed of the increase in the death rate decelerated beyond age 75. 
Similarly, Brownlee (1919:47 in Olshansky & Carnes (1997) suggested that 
the Gompertz equation does not apply equally throughout the age range; 
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"the graduation is made in two sections, one section from the age of 15 to 
the age of 50, the second beginning at the latter age and extending 
upwards to the end of life." In Perks' (1932:15 in Olshansky & Carnes, 
(1997)) development of the logistic equation to improve the graduation of 
death rates at older ages, he recognized that "the ungraduated rates and 
the rates by adopted graduation show a curious peak in the rate of 
increase in qx round about age 80 ...it is thought that the sharpness of this 
peak may be due in some way to an element of neglected selection which 
would naturally rapidly wear itself away at about age 80 ...". He further 
stated that "the graduated curve [of mortality] starts to decline in the 
neighbourhood of age 84" (p. 30). In Beard's (1959:303 in Olshansky & 
Carnes (1997)) discussion of mathematical mortality models, he 
recognized that "what evidence is available tends to support the idea that 
the force of mortality does not continue to increase indefinitely with age". 
Strehler & Mildvan (1960:311 in Olshansky & Carnes (1997)) argued that 
one of the four distinct phases of the human mortality curve was "a period 
of departure from the Gompertzian relationship at great ages so that 
mortality rises more slowly than anticipated after age 85-90." He argued 
that this phenomenon would occur "when the vitality has decreased to the 
point where it is similar to the average energy of fluctuations" (p. 314) 
about a homeostatic mean. One of Strehler &  Mildvan's (1960:217 in 
Olshansky & Carnes (1997)) "observations that any mathematical theory of 
mortality must incorporate into its postulatory structure, explain, or at 
least not violate" included the fact that "at extremely advanced age, the 
mortality rate curves of several species rise at a rate progressively lower 
than exponential" (p. 224). The limited applicability of the Gompertz 
function to only a specified range within the life span and a deceleration in 
death rates at older ages (including possible explanations for this 
phenomenon) have been recognized by many other researchers 
(Olshansky & Carnes 1997)17. 
 
                                                 
17 They cite the following references: Abernathy (1979); Brooks, Lithgow & Johnson 1994; Doubal 
1982; Economos 1980; Gavrilov & Gavrilova 1991; Horiuchi & Coale 1990; Horiuchi & Wilmoth 1999; 
Pakin & Hrisanov 1984; Riggs 1993; Weiss 1989; Witten 1988). 
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Thus the current situation with applicability of the Gompertz law to 
extreme old ages is still a paradoxical one (Gavrilov and Gavrilova 2002). 
On the one hand, it has been well known for a long time that the Gompertz 
law is not applicable to mortality rates at advanced ages- the observed 
mortality rates are always lower than predicted by the Gompertz model, 
and not surprinsingly, the actual number of survivors to extreme ages is 
always higher than predicted by the Gompertz law. The problem now is to 
find out which of these theories is correct.  
                     
 
3.2.2. Mortality trajectories with age. 
 
It has been known for some time that mortality increases with age, but is 
there an age at which death in the following year is certainty? And if yes, 
what is it? What determines the mortality ceiling? Can it drop significantly 
in the future? Explanations are put forward to explain the mortality 
trajectories with age. 
 
From 1950, the extinct generation method suggested by Vincent (1951) 
and its modern extensions (Meslé & Vallin 2000; Thatcher et al 2002) have 
been used to calculate the mortality rate for the oldest-olds accurately 
(Robine 2005). Creating a database covering several countries increased 
the number of observations (Vincent 1951; Dépoid 1973), but these 
remained limited until the K-Th Database18 created by Kannisto and 
Thatcher that includes mortality data from 30 developed countries 
(Kannisto 1994). This database is the foundation for all modern work on 
mortality trajectories that suggest that mortality among the oldest old 
                                                 
18 The recent progress in the demography of longevity is partly due to the constitution of international 
databases, such as the Oldest-Old Mortality Database, better known as the Kannisto-Thatcher 
Database (Kannisto, 1994), the Human Mortality Database (HMD), developed jointly by the University 
of California at Berkeley and the Max Planck Institute for Demographic Research at Rostock 
(www.mortality.org or www.humanmortality.de) and the International Database on Longevity (IDL), 
developed jointly by the University of Montpellier, the French National Institute for Demographic 
Studies (INED) and the Max Planck Institute for  Demographic Research (Robine & Vaupel 2002). More 
of such databases in the fields of gerontology, epidemiology, biodemography and biology would surely 
contribute to significant progress.  
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follow a logistic trajectory (Kannisto 1996; Thatcher et al. 1998; Thatcher 
1999) or a quadratic trajectory (Vaupel et al. 1998).  
 
Another database is the International Database on Longevity (IDL), which 
has objective to accurately calculate mortality rates between the ages 105 
and 115 years (Robine & Vaupel 2002). There is no doubt today that 
mortality slows down after the age of 85 and that mortality rates observed 
at ages 95 or 100 are lower than expected (Robine 2005). He cites as well-
known studies those by Barbi et al. (2003); Kestenbaum & Fergusson 
(2002) ; Lynch & Brown (2001); Weitz & Fraser (2001) ; Manton (1999); 
Horiuchi & Wilmoth (1999); Vanfleteren et al. (1998). 
 
Figure 5 summarises the knowledge on old age mortality trajectories with 
age. Vincent (1951) was able to estimate for the first time the age at 
which the probability of dying in the same year was close to 110 years. 
Twenty years later, Dépoid (1973) would find a limit age of 117 years old 
based on same hypotheses and methods. The logistic trajectory with age 
of Thatcher et al. (1998) tends towards a mortality ceiling without ever 
reaching it. Vaupel et al. (1998) found a quadratic trajectory, where 
mortality diminishes with age, having passed a maximum at around 110 
years old. The mortality rates between 110 and 114 years old, calculated 
extremely accurately thanks to the IDL (Robine & Vaupel 2002) show that 
mortality does not increase, or only very slightly, after 110 years of age.  
 
These results nevertheless show that human longevity has no limits in 
terms of age and there are no biologically-controlled limits (clock genes or 
other mechanisms linked to natural selection). If there really is a limit, it is 
for mortality levels that do not reach an annual mortality rate of 60%, 
even in people of 110 years old or more, even for the most frailty, under 
mortality conditions currently found in the most developed countries. 
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                 Figure 5: Mortality trajectory beyond 95 years of age 
                        
 
                     Source: International Database on Longevity- IDL, 2004 
 
 
3.2.3. Modelling of old age mortality by cause of death 
 
A first step in improving mortality projections is to analyse cause-of-death 
patterns, as each disease has its own cause. It has the added advantage 
that it not only improves the projection of mortality, but also the 
explanation for mortality differences over time (Spijker  2004:6-7). 
 
The cause-of-death approach is perhaps the most encouraging, particularly 
for short-term forecasting, because of the simplicity of the 
parameterisation functions for mortality-by-cause and by the fact that 
epidemiological knowledge can be used to formulate hypotheses. However, 
there are certain difficulties associated with this approach. For instance, 
bias may result from misclassifications of deaths that could result in cross-
correlations between mortality trends from different but related causes. A 
more important implication for my future PhD research, however, is the 
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fact that the underlying cause of death is less easily identified with regard 
to deaths at the most advanced ages (Tabeau et al. 2001).  
 
Differences in the outcomes and accuracy of overall mortality and cause of 
death-based forecasts of total mortality have been recently discussed by 
Tabeau et al. (2001), who reviewed studies conducted by Wilmoth (1995), 
Caselli (1996) and Alho (1991), which are briefly summarised below. 
 
Wilmoth (1995) showed analytically for the proportional rate of change 
models which are linear in parameters that forecasts of morality obtained 
from the aggregation of mortality by cause must eventually exceed 
forecasts based on mortality data by all causes taken together. From 
Caselli’s projections (Caselli 1996), another pattern of results has 
emerged. In general, projections of trends in mortality by cause in all 
countries reduced the advantage enjoyed by females and increased that 
for men, for whom the gains in life expectancy were larger when estimated 
by cause than those obtained from total mortality-based projections. Alho 
(1991) discussed the effects of aggregation on the estimation of trends in 
mortality. In some cases, Alho suggests that the aggregate forecasts 
appear to be more credible. He states that several factors are capable of 
influencing the potential for disaggregation-related gains in forecast 
accuracy. The effects of misclassification of deaths by cause, the cross-
correlation between causes, the similarity of auto-correlations in different 
causes, modelling bias, and expert judgement are all examples of such 
factors. The results of different approaches are not similar if one or more 
causes serve as ‘leading indicators’ for the remaining causes, or outside 
information is incorporated into forecasting either through expert 
judgement or formal statistical modelling. Also, under highly non-linear 
models or in the presence of modelling errors the results may not be 
similar. 
 
A difficulty of the cause-of-death approach is that the underlying cause of 
death cannot be easily identified for ages after approximately 90 years, 
which implies that cause-specific projections can only extend up to a 
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relatively low age. Thus, modelling mortality of the oldest-old cannot take 
place within the framework of the cause-specific approach (Tabeau et al. 
2001). It must be stressed that old-age mortality is the key component of 
any projection model in the overall period and cohort forecasting 
approaches. The hypotheses chosen for this component are crucial to the 
outcome of the forecasts, but their formulation is difficult. The hypotheses 
can no longer be formulated on the basis of past experience, but should be 
based on a source other than mortality, such as research on longevity, as 
explanatory models of mortality are extremely relevant.  
 
 
3.2.4. Mortality models incorporating theoretical concepts of  
            ageing 
 
Understanding why and how we age requires interdisciplinary efforts, and 
these include research in actuarial science, demography, gerontology, 
biology and so forth. There is an accumulated knowledge in different 
disciplines for the description of the ageing process, and the impact of 
these characteristics on mortality are represented in this models below.  
 
Simms (1942) found that some important physiological characteristics 
connected with an individual’s ‘vitality’ are different for individuals of the 
same age. This finding generated a new way of thinking about mortality as 
it is estimated in population studies and about biological and physiological 
characteristics of ageing.  
 
Yashin (2001) reviewed several approaches to modelling the age pattern of 
mortality that incorporate theoretical concepts of ageing that have 
contributed to our understanding of the basic regularities of ageing and 
survival and shows how theories and types of observations influence the 
structure and scope of applications of mortality models. 
 
A major characteristic of the earlier theories and models of mortality is that 
they associate the dramatic decline in the vitality of the organism. 
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However, reviews of physiological studies of ageing carried out by Shock 
(1960,1974) and later by Bafitis & Sargent (1977) showed that various 
functions characterising physiological capacities in humans decline more or 
less linearly with age. 
 
Strehler & Mildvan (1960) combined in their mathematical model the 
Gompertz curve with the assumption that the death rate at a given age is 
proportional to “the frequency of stresses which surpass the ability of a 
subsystem to restore the initial conditions” at that age. They showed that, 
under such an assumption, the exponential increase in mortality is related 
to the linear decline in vitality. 
 
Atlan (1968) modified Strehler & Mildvan’s theory. He suggested 
expressing vitality in terms of entropy rather than of energy. According to 
Atlan, ageing is a process of progressively increasing entropy, meant as a 
decrease in the information content of the organism, until a level is 
reached that is incompatible with life. Atlan claimed that the linear portion 
of the curve corresponds to the exponential variation in the mortality rate 
(Gompertz curve) and that the subsequent portions correspond to the last 
part of the mortality curve, which deviates from Gompertz for old ages and 
moves towards a constant mortality rate. 
 
Sacher & Trucco (1962) suggested a stochastic mechanism of ageing and 
mortality, in which the individual chances of death are regulated by 
random fluctuations of internal and external origin. In other words, they 
suggested a model of mortality that includes both homeostatic forces and 
random fluctuations of physiological variables. They also assumed a linear 
decline in the homeostatic capacity with age. 
 
Simms (1948) viewed the stochastic nature of mortality as resulting from 
biological forces acting randomly within individuals who then become 
different as they grow older. 
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Szillard (1959) developed the genetic theory of mortality and ageing. 
According to his model, “the main reason why some adults live shorter 
lives and others live longer is the difference in the number of faults they 
have inherited”. 
 
Beard (1959) proposed a model of heterogeneous mortality which results 
in the logistic curve of the observed hazard. He claimed that the 
distribution of heterogeneity can be looked upon as an index of the genetic 
make-up of the population. He then assumed that the distribution of 
individuals by cause of death reflects this heterogeneity. 
 
Vaupel et al. (1979) conceptualised the idea of population heterogeneity in 
mortality and introduced the notion of individual frailty as a measure of 
individual differences in the chances of survival in the proportional hazards 
model. His model of hidden heterogeneity in survival (frailty) was an 
important step towards a better understanding of the observed age 
patterns of mortality. In particular, the idea of heterogeneity was used to 
explain the deceleration and levelling off of mortality rates at late ages. 
 
Charlesworth (1990) suggested a quantitative genetic model of 
senescence, which includes the effects of mutation pressure. The model 
predicts that the additive genetic variance for mortality rates should 
increase with age, and that, if deleterious mutations are completely age-
specific in their effects, then a total collapse of survival would occur at later 
ages. This means that the mortality rate tends to infinity at a finite age 
interval.  
 
Abrams & Ludwig (1995) explored the relationship between mortality and 
age that would hypothetically occur when individuals used the energy and 
resources normally spent on reproduction on the maintenance and repair 
of the organism.  They predicted a marked deceleration of mortality rates 
and the death rate still tended to infinity with age. 
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Mueller & Rose (1996) developed a model for the calculation of mortality 
trajectories in a hypothetical population using the assumptions of either 
antagonistic pleiotropy or mutation accumulation (see Chapter 2 for their 
respective definitions). They concluded that the standard evolutionary 
theories explain late-life mortality plateaus. 
 
 
3.3 Data types, sources and quality.  
 
A frequently mentioned problem in studies dealing with mortality is the 
unreliability of age reporting at advanced ages. Ages of older persons tend 
to be misreported, and are more likely to be exaggerated rather than 
understated. This transfers some persons of relatively younger age in 
which mortality is lower to older age groups with higher mortality. This 
leads to the underestimation of mortality rates at old ages and the 
overestimation of the expectation of life unless the age at death is 
exaggerated considerably more than the ages of living persons, which 
would inflate mortality at those older ages that are reported (e.g. 85, 90, 
95 etc.). To eliminate these errors, two steps are usually taken (Redfern 
1974). 
 
1. To improve the number of death at old ages that enables to 
reestimate old-age population numbers and deaths. To give an 
example, several developed countries use such adjusted death and 
population statistics as those that have been made available by the 
K-T database. The data from this collection meet the criteria of 
reliability and consistency for the 30 developed countries that are 
included, but much still remains to be done to improve the old-age 
population and mortality statistics of less developed countries. 
 
2. To use mortality measures to solve problems of incomplete data 
(e.g. Preston, Elo & Stewart 1999). 
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With regard to the different types of population and vital statistics data 
sources available, that is, continuous population registers, death 
certificates and censuses, there are three principal advantages of using 
data from continuous population registers over data from death certificates 
and censuses. First, we should consider the validity of age recording. At 
birth a personal card based on the birth certificate is made and all changes 
in vital status, including death, are recorded on this card. Second, 
population registers also provide data on the population at risk by single 
year of age and sex. Finally, mortality data by single year of age at death 
and year of birth are available for all ages, including centenarians. 
 
There seems to be need for a method of estimating the expectation of life 
at old ages directly from data on mortality in old age that is robust in the 
presence of substantial misreporting of ages (Horiuchi & Coale 1982). 
 
 
3.4. Male-female differences 
 
The important question in this context is whether the differential increase 
in the force of mortality is due to a differential ageing process between 
males and females, or whether this difference can be attributed to a 
stronger selection of the male population towards low-frailty individuals 
that is caused by the higher overall level of male mortality.  
 
When comparing the ‘male’ and ‘female’ patterns of contribution, the 
pattern for women should be given more weight at the higher ages than 
the pattern for men. Because sex differentials in mortality are large at the 
older ages, the larger proportion of those surviving to older ages are 
women, leading to a “feminization” of the adult and elderly population. 
(Gomez &  Boe 2005). 
 
So differential mortality by sex continues to benefit women, they continue 
recovering from the century a lost biological advantage that, together with 
healthier behaviour and different life conditions, have also guaranteed a 
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social advantage in front of death (Vallin 2002; Waldron 1983). But in the 
future it is possible that in developed countries a different and regressive 
profile may arise since women have incorporated the habits and life styles 
characteristic of men. These factors, which regulate differential mortality 
by gender, are considered as undesirable outcomes in terms of both 
current female mortality patterns and future trends. For instance, in terms 
of life expectancy, many northern and western European countries have 
witnessed a decline in gender differences since the 1980s (Council of 
Europe 2003), which researchers have related to the significant changes 
that occurred during the same period in the life style, education, family 
roles and employment of women (Annandale & Hunt 2000; Waldron, 1983; 
Spijker et al. 2007). 
 
 
3.5. Conclusions 
 
 
Mortality at old age is a crucial component of any forecasting model for 
overall mortality. At the same time, more problems are inherent in the 
measurement and modelling of mortality at old ages than at lower ages. In 
effect, more uncertainty must be expected in the forecasts of old-age 
mortality.  
 
Most discussions about old-age mortality have focused on its trends, levels 
and age patterns and there is no doubt today that mortality slows down 
over and beyond the age of 85 and that mortality rates observed at 95 or 
100 years old are lower than expected. But among researchers there is 
little agreement with respect to the age patterns of old-age mortality. 
Some researches suggest that mortality increases exponentially with age, 
following the pattern of a Gompertz curve. Others state that human death 
rates increase exponentially with age from approximately 30-35 years to 
80-85 years (e.g. Horiuchi & Coale 1990). Regarding the choice of 
preferable methods, the answer is clearly related to the type, the extent, 
and the quality of the data available at the moment of projection.  
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Mediterranean Fruit Fly 
 
CHAPTER 4 INCORPORATING BIODEMOGRAPHY INTO THE   
MODELLING OF OLD AGE MORTALITY          
 
4.1. Introduction19 
 
The biodemography is a multidisciplinary approach that arose in the late of 
20th century as a product of efforts to integrate biological knowledge 
(studies on human biology and animal models) with demographic research 
on human longevity and survival. Researchers in this emerging field have 
discovered attributes of ageing and death in humans that may very well 
change the way epidemiologists view and study the causes and of disease 
(Olshansky et al. 2005). 
 
The earliest antecedents to the modern biodemography date back to the 
French zoologist Georges Buffon (1749), who demonstrated that “physical 
laws” regulate the duration of life in humans and other species. These 
physical laws, according to Buffon, link the biological clocks that he 
thought influenced the duration of life. He hypothesized that each species 
has a characteristic maximum life span and that this maximum life span is 
six or seven times the duration of the period of growth. The British actuary 
Benjamin Gompertz (1825) provided the first mathematical support for this 
view. Specifically, he found that the force of mortality increases in 
geometrical progression with the age of adult humans. According to him, 
human mortality rates double over about every eight years of adult age. 
                                                 
19 Vaupel,J.W  (2004) .The Biodemography of Aging Population and Development Review, Vol. 30, 
Supplement: Aging, Health, and Public Policy. pp. 48-62. 
 
“My hunch is that much of the future growth of the field of demography will be 
in the direction of our legitimate but under explored territory in the biological 
sciences” 
                 James W Vaupel (2004)19 
                     
 62 
The linkage between Buffon’s early life events and Gompertz’s regularity in 
the timing of death appeared many years later with empirical evidence 
demonstrating that for some species, duration of life is calibrated to the 
onset and length of the reproductive window (i.e. at menopause) (Carnes 
et al. 1996). These observations serve as the foundation of the 
biodemography discipline.  
 
The theoretical basis for the biodemography is derived principally from 
evolutionary biology (Kirkwood 1977; Hamilton 1966; Medawar 1951; 
Williams 1957), but it has roots in historical efforts of scientists who 
speculated on what was referred to as a “law of mortality” (Greenwood 
1928; Brody 1924; Brownlee 1919; Makeham 1867; Gompertz 1825) - the 
observation that a consistent age pattern of death occurs across species 
(Carnes et al. 1996; Charlesworth 1994; Carey et al. 1992; Gavrilov & 
Gavrilova 1991; Finch 1990). The modern notion of the biodemography 
arose in the late 1980 and early 1990s, when scientists from a broad range 
of scientific backgrounds began speculating about the biological forces 
responsible for the similar age patterns of death that they observed among 
sexually-reproducing species. Including James R. Carey, James W. 
Curtsinger, Thomas E. Johnson, Vaino Kannisto, Pamela Larsen, Hans 
Lundström, A. Roger Thatcher, Anatoli I. Yashin, James Vaupel, and others 
— succeeded in peering into the remote regions of survival for five species 
— Homo sapiens, Drosophila melanogaster, Ceratitis capitata (better 
known as the medfly), Anastrepha ludens (the somewhat larger Mexican 
fruit fly), and Caenorhabditis elegans (a nematode worm) (Wachter & Finch 
199720).  Thus, interest in integrating biology into demography in the 
context of ageing and longevity began to grow.  
 
There are at least three general ways by which the inclusion of 
biodemographic concepts in demography coursework can strengthen the 
field (from Carey & Judge 2001).  
                                                 
20 Demographer Kenneth Wachterk and molecular biologist Caleb Finch (1997),in the opening and 
ending chapters, respectively do explore the central questions at the  core of  biodemography - which 
are  appropriately captured by2 the graphic title, Between Zeus and the Salmon. Zeus, the principal 
(immortal) god of the Greek pantheon, and salmon, genetically programmed to die shortly after they 
reproduce, represent the extremes that bound the study of ageing and longevity (Olashansky 1998). 
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1. Biodemographic principles provide a scientific knowledge that is 
lacking in conventional texts on demography and actuarial science. 
 
2. Biodemographic principles can provide explanations for life table 
patterns in human populations that are not evident in the absence of 
broader biological concepts. For example, they suggest explanations 
of sex differentials in life expectancies, why older individuals may 
grow old more slowly, whether life span limits exists, whether post-
reproductive life is common or rare and if how post-reproductive life 
spans in other species increase fitness.  
 
3. Biodemographic principles can be used as a more secure foundation 
for qualitative predictions in the context of old-age mortality, upper 
limits of life span, and the magnitude and sign of the gender gap 
(Carey & Judge 2000; Wilmouth 1998). For example, it was not 
known until the results of animals studies were reported showing 
similar patterns whether slowing of mortality at older ages in 
humans was an artifact of small numbers of observations, a period 
effect, or real (Vaupel et al. 1998). 
 
I believe that incorporating the field of biodemography will provide context, 
perspective and a frame of reference for the interpretation and modelling 
of human actuarial data (see Carnes & Olshansky 1993; Olshansky & 
Carnes 1997 for historical review) and will shed new light on those factors 
correlated with the life history of our species and those factors explaining 
demographic variations between populations. 
 
 
4.2.     Principles of Biodemography 
 
The broad purpose of this section is to describe what Carey & Judge (2001) 
consider to be the most fundamental and important principles in 
biodemography that apply to a wide range of species including humans. I 
consider that these principles are important because they summarize and 
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synthesize many of the general demographic properties and concepts that 
apply to a wide range of species. The construction of this preliminary set of 
general principles encourages a greater communication between 
demographers and biologists by defining a common goal- identifying 
general demographic patterns (Carey 2001). Each of the principles listed 
above are general and therefore applies to virtually all species including 
humans of course. 
 
1. Principle of senescence: senescence is a product of natural selection 
on survival versus reproduction. Medawar (1951) demonstrated that 
age-structured populations result from the chance application of 
mortality even in reproducing but non-senescing populations. In 
age-structured population, the force of natural selection decreases 
with age. Because more individuals of early age exist than 
individuals of older age, selection acts more forcefully among early 
expressing variable traits than among those traits that are only 
expressed later.   
 
2. Principles of mortality: the single most important function of the life 
table is age-specific mortality, the fraction of individuals alive at age 
x that die prior to age x+1. Below I describe mortality concepts that 
Carey & Judge (2001) considered relevant to understanding 
mortality in humans. 
 
• Death versus failure: the term “death” is often used in 
metaphorical context such as automobile accident as the death of 
car. This distinction between literal and metaphorical is important in 
the context of mortality or death rate. Whereas cars can fail and 
therefore possess a failure rate, only living organisms can die and 
therefore possess a true death rate. This distinction is important in 
biodemography because of the argument that complexity may 
explain similarities in the age-specific patterns of death (or failure) 
in mechanical and biological systems (e.g. Abernethy 1979; Vaupel 
et al. 1998). 
 65 
• Mortality deceleration at advanced years: mortality rates slow 
in virtually all organisms at older ages. This deceleration implies 
that there is no definite upper limit to life span. 
 
• Sex-specific mortality: the mortality response of males and 
females of virtually all species will be different in similar 
environments. Female-longevity advantage is not universal across 
species.  
 
• Mortality trajectories: The trajectory of mortality in all species 
including humans is “facultative”: a term used in biology to describe 
life history traits with alternative conditions that vary with 
environmental conditions. 
 
• Demographic selection: As population age, they become more 
selected because groups with higher death rates die out in greater 
numbers than those with lower death rates, thereby transforming 
the population into one consisting mostly of individuals with low 
death rates (Carey & Liedo 1995; Rogers 1995; Keyfitz 1985; 
Vaupel et al. 1979). 
 
• Subdetectable mortality: a major concern of any study 
designed to estimate mortality rates at older ages in a cohort is 
sample size. The number of individuals at risk of dying becomes 
progressively less with age due to attrition. Consequently the 
sample size needed to measure mortality at older ages may be 
insufficient. Death rate cannot be measured below 1/n where n is 
the cohort size. In conclusion, this problem with “demographic 
sampling error” can bias estimates of rates of ageing, age at onset 
of senescence, costs of reproduction, and demographic tests of 
evolutionary models of ageing (Promislow et al. 1999). 
 
• Mortality variance increases with cohort age: Human life 
tables at the younger ages are constructed from tens of thousands 
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or millions of deaths. Statistical properties such as the standard 
deviation and variance of mortality at each age are small and thus 
inconsequential. However, in biology, life tables are frequently 
based on a smaller population (either by design or because some 
animals live long and are expensive to maintain), making life table 
information more deficient as the number of individuals in a cohort 
decreases with age that causes the variance to increase. Such 
statistical problems are also becoming important in human 
populations, particularly at very old ages. 
 
3. Principles of longevity: longevity refers to the period between birth 
and death of an individual. 
 
• Longevity is adaptive: In evolutionary biology an “adaptation 
“is a characteristic of organisms whose properties are the result of 
selection in a particular functional context (West-Eberhard 1992). 
Thus, life span is evolved to solve particular ecological problems 
such as bridging unfavourable periods (droughts) or, for humans 
and other species, as a co-adaptation with sociality. This finding is 
important because it suggest that extended longevity should be 
considered along with features such as a large brain, bipedalism 
(standing on two appendages) and language as a key trait of our 
species (Carey & Judge 2001). 
 
• Maximal age is influenced by sample size: The value of the 
parameter “maximal age” is dubious because the magnitude of the 
largest characteristic life span grows with an increase in the number 
of observations (Gavrilov & Gavrilova 1991). This is a general 
principle of statistics. The extent of the sample size affect is also 
affected by the shape of the survivorship curve. The more 
rectangular the survivorship curve the less variation in maximum 
observed life span with sample size (Calder 1996). 
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• Life span is indeterminate: maximal length of life remains as 
one of the most compelling concepts in demography. The validity of 
this concept is viewed by many as self-evident because different 
species exhibit different life expectancies; all individuals eventually 
die before the age of infinity; and therefore, each species must 
possess unique and finite maximal ages. Thus, life span is open-
ended and dynamic; it is most usefully considered in the context of 
a species’ ecology and evolutionary biology.  
 
• Reproduction as a longevity determinant: Most organisms, 
from yeast and plants to invertebrates, birds and mammals, 
suspend reproduction during periods unfavourable for reproduction 
by entering a different physiological mode. Such waiting strategies 
for prolonging survival while maintaining reproductive potential have 
been extensively documented in the physiological, ecological and 
natural history literature (see Carey et al. 1998). In other words. a 
unit increase in reproduction at young ages causes a unit decrement 
in mortality at older ages. More generally, reproduction and 
mortality are inextricably linked (see MacInnes & Pérez Díaz  2005). 
 
• The heritability of individual life span is small: life span 
heritability is defined as the proportion of the variance among 
individual ages of death that is attributable to differences in 
genotype (see Futyuma 1998). Contrary to popular myth, parental 
age at death appears to have minimal prognostic significance for 
offspring longevity (McGue et al. 1993). 
 
Thus, these principles provide an important base to understand human 
birth and death rates, because the principles can help formulate questions 
being relevant to future directions and encourage biologists and 
demographers to identify other general demographic patterns.  
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4.3. The major biodemographic findings  
 
My broad objective in this part is to use the results of studies in biological 
species to demonstrate the relevance and importance of biodemographic 
perspectives in human population studies such as the trajectory of 
mortality at older ages, sex mortality differentials or the concept of 
maximal life span.  
 
Late-life mortality deceleration 
 
Attempts to develop a fundamental quantitative theory of ageing, mortality 
and life span have deep historical roots. As we have seen in 1825, the 
British actuary Benjamin Gompertz found what he referred to as the “law 
of mortality”21 (Gompertz (1872, 1862, 1825, 1820). Specifically, 
Gompertz model suggests that the number of living organisms decreases 
in geometrical (exponential) progression as age increases in arithmetical 
(linear) progression so this implies that the probability of dying with age 
increases exponentially after age 15 (Finch 1990; Pressat 1985). 
 
The Gompertz model has been used widely in gerontology for fitting 
mortality schedules of nonhumans species (Finch 1990) and for comparing 
rates of actuarial aging between and among different species. (Comfort 
1979; Gavrilov & Gavrilova 1991; Lamb 1977). It is also used in 
demography for smoothing the mortality functions of recorded life tables 
(Pressat 1985), for developing model life tables (Coale & Demeney 1983), 
and for projecting numbers of persons living to older ages (Bell, Wade 
&Goss 1992). On the other hand, Economos (1982) and others (e.g. Carey 
et al. 1992; Gavrilov & Gavrilova 1991) reported non-Gompertzian 
patterns of mortality at older ages in insects and humans.  
                                                 
21 The Gompertz model is recognized by most demographers and gerontologists as an empirical model 
and not a “law” (Finch 1990), but not all gerentologists and medical researchers agree. For example, 
Fries (1983) stated that “ Gompertz’s law appears to hold in all populations and assures an 
exponentially increasing mortality rate and, therefore, death for the entire population within a decade 
or two past the age of 100”. 
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This late-life mortality deceleration is a confuse observation. Gompertz 
himself, as well as numerous other scientists of the nineteenth and 
twentieth centuries, stated explicitly that his model did not apply, and in 
fact was never intended to apply, to older regions of the lifespan. For 
example, both Gompertz (1872, 1825) and Makeman (1867) recognized 
that the rise in human mortality decelerates at older ages. Makeham 
stated that for humans “the rapidity of the increase in the death rate 
decelerated beyond age 75”. Perks (1932) identified a “curious peak in the 
rate of increase in death rate round about age 80” and observed that “the 
graduated curve of mortality starts to decline in the neighbourhood of age 
84”. Strehler & Mildvan (1960) argued that one of the four distinct phases 
of the human mortality curve was “a period of departure from the 
Gompertzian relationship at great ages so that mortality rises more slowly 
than anticipated after age 85-90”. Strechler & Mildvan (1960) extended 
this to other species by noting that “at extremely advanced age, the 
mortality rate curves of several species rise at a rate progressively lower 
than exponential”. More recently, Vaupel (1997) expressed that “until 
recently, it was impossible to determine whether this exponential rise 
continued to advanced ages”. For humans, the scattered data available 
suggested that death rates keep on going up with age up to advanced ages 
but the rate of increase slows down, in other words mortality decelerate at 
the highest ages, but questions about data reliability precluded strong 
conclusions. For some species, virtually nothing was known about mortality 
at advanced ages because the populations studied had been too small to 
permit dependable estimates of death rates at ages that only a small 
fraction of the starting cohort reached (Carey et al. 1992) and for some 
other species, such as medflies, death rates reach a plateau and then fall 
dramatically. A number of other studies (Wang et al. 1997; Clark & 
Guadalupe 1995; Tatar & Carey (1994a, 1994b); Vaupel, Johnson, & 
Lithgow 1994; Curtsinger et al. 1992) reinforce this finding. 
 
Although many attempts have been made to test the Gompertz model, the 
problem to find out when this model is correct still continues. Similarly, the 
reason why mortality decelerates at older ages in all the species (include 
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humans) for which large, careful studies have been conducted is also 
unclear. Thus, further research is warranted because as Vaupel (1997) 
asserted “at present it seems implausible that all of the observed 
deceleration of mortality at older ages is an artefact of heterogeneity”. 
 
Female longevity advantage  
 
The prevailing wisdom in gerontology is that the female advantage in life 
expectancy is a universal law of nature. Unfortunately the scientific 
literature on sex longevity differences is ambiguous and it is still impossible 
to use the results of mortality studies on medflies or other species to 
predict the direction, rate of change, and extent of the human gender gap 
in the future. Some argue that females’ greater longevity is essentially a 
universal law of nature (Hazzard 1990; Brody & Brock 1985; Hamilton & 
Mestler 1969) whereas others suggest that males of most species exhibit 
about the same life expectancy as females (Gavrilov & Gavrilova 1991; 
Smith 1989; Smith & Warner 1989; Lints et al. 1983)22.  
 
I share the view with Carey and Liedo (1995a) that there were at least 
three reasons why it is impossible to state unequivocally that either males 
or females live longer. On the basis of their medflies study they found that: 
 
1. Longevity can be characterized in a number of different ways 
(e.g., life expectancy at eclosion [day 0], life expectancy at 
day 30, age when 90% of the original cohort is dead (life 
endurancy, maximal life span, etc.); Carey and Liedo 
discovered that one measure of longevity often favoured one 
sex, whereas another measure favoured the other sex.   
 
2. The considerable variation among cohorts for a given 
longevity measure. For example, neither male nor female 
                                                 
22 For additional perspectives on male-female differences in longevity see Hamilton 1948; Hazzard et 
al. 1991; Hazzard & Bowden 1990; Lopez & Ruzicka 1983; Manton et al  1995; Nathanson 1984. 
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longevity was greater in all of the groups regardless of the 
measure used.  
 
3. Relative longevity for the two sexes was conditional on the 
environment in which they were maintained or the treatment 
to which they were subjected. For example, expectation of life 
for males and females was similar if flies were maintained in 
solitary confinement but favoured males if the flies were 
maintained in grouped cages. 
 
I strongly believe that these same issues could arise in comparing other 
nonhuman species and that knowledge of whether the female advantage 
longevity or not is a general characteristic of nonhuman species would 
provide an important biological context for interpreting the current and 
predicting the future of the gender gap in humans.  
                       
Life span limits23 
 
A fundamental question in population research is whether humans and 
other species possess a fixed life span limit and it remains as one of the 
most compelling concepts in human biology and demography. Although 
there has been considerable debate on whether the human life span is 
fixed, the evidence now appears to support the notion that no single 
number can be assigned as the life span limit of a species (Carey 2003). 
 
Works since 1990 have been realized to try to understand this limits 
(Carnes et al 2003; Bongaarts & Feeney, 2002; Olshansky & Carnes 2002; 
Vaupel 2002; White 2002; Wilmoth (2002,2001,2000,1998); Olshansky et 
al. 2001; Riley 2001; Gavrilov & Gavrilova 1998; Vallin & Caselli 1997; 
Manton & Stallard 1996; Kannisto 1994; Olshansky & Carnes 1994; Carnes 
                                                 
23 The oldest verifies age to which a human being has ever lived is 122 years and 167 days, a record 
held by the Frenchwoman Jeanne Calment, who was born on 21 February 1875 and died on 4 August 
1997 ( Allard et al.1998). Other verified long livers include Sarah Knauss, Mare Meiller, Chris Mortinson 
and Charlotte Hughs, who lived 118.1, 117.6,115.8 and 115.6 years (Robine & Vaupel 2001). Recently 
on 5 March  2004 died in Migjorn Gran (Spain) Joan Riudavets Moll who lived 114 years. 
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& Olshansky 1993; Vallin (1993,1992); Manton et al. 1991). Kannisto 
pointed out that the problem with this concept is that our knowledge of the 
nature of mortality makes it difficult to accept the notion that there is an 
age that some may reach but that no one has any chance to surviving. 
Manton and Stallard noted that declines in the age rate of increase of 
mortality for male and female cohorts in the U.S. are inconsistent with a 
fixed life span limit. Gavrilov and Gavrilova also rejected the notion of a 
human-specific upper age limit; they argued that people die before the age 
of infinity, not because they cannot pass some bounding age, but because 
the probability of a person avoiding the ever-present risks o death for that 
long is infinitesimal. On the other hand, in spite of the recent patterns of 
declines in mortality at the oldest ages and major increases in the 
prevalence of centenarians, there is still considerable support for the 
concept of a definite upper life span limit for humans (Olshansky et al. 
2001; Vaupel et al. 1998; Manton, Stallard & Tolley 1991; Olshansky, 
Carnes & Cassel 1990; Fries 1980). 
 
The ambiguity of the concept of life span limits is also evident from 
different species mortality data. It has been demonstrated that the results 
of large-scale life table studies in virtually all species that have been 
examined reveal a deceleration in mortality at older ages. If a single life 
span limit existed for all species, a pattern of records of the long lived 
should begin to appear for a least some of the species for which longevity 
information is available. However, this is not the case: there is no 
clustering of longevity records from independent sources for thousands of 
species for which life span data are available (Carey & Judge 2000). 
Moreover, the concept of a fixed species-specific life span is itself 
misleading because of issues such as species strains, biotype, sex, hybrids 
and seasonal variants. For example, no single life span exists for 
honeybees even in theory since queens live 4 to 6 years, workers 6 weeks 
and drones from a few days to several weeks (Wilson 1971). A similar 
problem exists for the domestic dog with its scores of breeds each with 
different life spans (Patronek et al. 1997). 
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I would like to share the view of Wilmoth & Lundstrom (1996) when he 
suggested “that the relevant limit of human life span may be in the pace of 
improvement rather than in the ultimate level to be attained”. 
 
 
4.5. Conclusions 
 
My broad objective in this chapter was to develop a framework for the 
emerging field of biodemography. I started the chapter with an 
introduction of the discipline, then I described sets of general principles on 
mortality and longevity derived from Carey & Judge (2001) research on 
model systems and various longevity data sets on both human and non-
human species.  
 
The integration of biology into demography will provide a deeper 
understanding of demographic processes and insights into what patterns 
are common to a broad range of species and humans as well so, I think 
that now is an exciting time for those who are studying biodemography. 
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CHAPTER 5   DISCUSSION 24 
 
5.1. Discussion  
This question of the art has been a review of the older as well as the recent 
literature about old age mortality in developed countries. The evolution in 
mortality among the oldest old has been discussed in terms of the 
Epidemiological Transition, the Compression of Mortality, the Limit of 
Human Life Span and the Rectangularization of the Survival Curve, in 
which one could affirm that the oldest old today is the fastest growing 
segment of the population in most developed countries. As old age 
mortality will be the key component responsible for changes in mortality in 
the future, forecasting survival, health or mortality for the oldest over the 
next decades has become an urgent political need, as developed societies 
aim to avoid a likely financially overstrained social insurance and medical 
systems. 
 
What is uncertain, however, is whether this current trend in old age 
mortality will continue or not. Although there is a vast amount of 
accumulated knowledge that is specific to human mortality I believe that 
this is a good moment to review part of this literature, in particular that is 
                                                 
24What is the most you like of your sport? The freedom and life’s smell.  Solobici nº 191 pag.145.2007.  
José Hermida holds his position within the top of the world with impressive consistency: On world cup 
races he became two times runner-up, he finished three times on place four and was one of the hottest 
favourites in almost every race he started in. As his country’s most prominent mountain biker, he is 
very experienced: From the junior ranks to the espoirs and elite, he celebrated significant successes in 
all categories, crowned so far by the Olympic silver medal in Athens. No matter if the course is techni- 
cally simple and fast or extremely tricky and demanding, Hermida is always a candidate for the 
podium. It seems only a question of time until José goes for the rainbow jersey, and who knows, 
maybe he will be able to improve his best Olympic result in Peking. 
(http://www2.meridabikes.com/en_INT/Team.Hermida). 
 
¿Que es lo que más le gusta de su deporte? la libertad y olor a vida  
      Jose Antonio Hermida 24 
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related to the slowing down of old age mortality, as this will form part of 
the theoretical framework of my PhD thesis. 
 
When I was in my first year of the PhD course I got by chance an article by 
Dudley Lirk25(1996) where he made the following observation about the 
Demographic Transition Theory: “Demography is a science short on theory 
but rich in quantification. In spite of this it has produced one of the best-
documented generalizations in the social sciences: the demographic 
transition.” Between demographers there is a debate if the demographic 
transition is or not a theory. Dudley denoted that “For some, transition 
theory lies at the centre of modern scientific demography. Demeny (1972) 
has called it ‘the central preoccupation of modern demography’. To others 
it is a non-theory to be dismissed as an unproven generalization unworthy 
of much discussion (Coleman and Schofield 1986)”. 
 
I have made this reference because I saw a similar situation with 
Gompertz’ law. Even though the Gompertz’s law of mortality captured the 
attention of scientists for the past 170 years the current situation with 
regard to the applicability of his law as a general one is ambiguous. This is 
recognized by most demographers as an empirical model and not a “law” 
(Finch 1990), but not all researchers agree. For example, Fries (1983) 
stated that “Gompertz’s law appears to hold in all populations and assures 
an exponentially increasing mortality rate and, therefore, death for the 
entire population within a decade or two past the age of 100”. Willekens 
(2001) said that “The Gompertz is without doubt the best known model, 
used in a range of disciplines from botany to sociology”. 
 
As regards to my future research (i.e. the PhD thesis), after having 
reviewed the literature, I would like to go deeper into forecasting mortality 
of the oldest old. As we know, the oldest old population is growing. 
However, even though several leading forecasting mortality models (e.g. 
Makeham, Thiele, Perks, Helliman & Pollard) contain the Gompertz’s model 
as one of their components, the Gompertz’s law does not apply to the 
                                                 
25 Kirk D (1996). Demographic Transition Theory. Population Studies, 50,361-387. 
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entire age range, including the population that I would like to study: the 
oldest old. Moreover, as was concluded in Chapter 3 of this PhD research 
report, there also exist a difficulty in applying the cause-of-death approach 
for the oldest old as the underlying cause of death cannot be easily 
identified, which implies that cause-specific projections cannot be 
performed for very old age groups. Thus, because the Gompertz model as 
a unique model seems to be limited, my idea for the PhD thesis is to start 
with Gompertz’s law and linked it with a mortality model that incorporates 
theoretical concepts of ageing such as  Strehler & Mildvan (1960), Sacher 
& Trucco (1962), as well as the fixed heterogeneity and debilitation 
models. They provide explanations for Gompertz (exponential) patterns 
and for the ‘leveling off’ pattern of mortality” (see Chapter 3 and Yashin et 
al. 1994 for a review).  
 
On the other hand, I think that demography like other disciplines is faced 
with the continuous need to adapt new issues such as new concepts in life 
table analysis, advances in census techniques, new models for forecasting 
mortality, a better understanding of why and how we age and so forth, 
something which requires interdisciplinary efforts. In my opinion 
demographers who study mortality have much to gain by acquiring a basic 
understanding and awareness of developments in many different areas 
such as biostatistics, genetics, molecular biology and gerontology.  
 
In Chapter 2 of this work I have seen that the Evolutionary theories of 
ageing have made an important contribution for the understanding of our 
evolution. But, even these theories still continue to be weak in explaining 
observed mortality patterns and I think that studies on the evolution of 
species may provide us with a better understanding of the role of the 
oldest old in nature. In my opinion, new models are needed to better 
understand the regularities of the evolution of life history traits among 
species that will aid in the understanding of our evolution as humans. 
Thus, for my PhD thesis I would like to go deeper into the field of 
biodemography, starting with the biological explanations of oldest old 
mortality. 
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Finally, I should mention than when modelling old-age mortality, it is vital 
to work with high-quality age-specific data. For example, data series 
truncated at age 75 are of little value, because mortality as a function of 
age increases at different rates in different age intervals. An important 
feature is the acceleration of the age-related increase in mortality at ages 
approaching 75 years and then a deceleration among those above the age 
of 85. Thus, methods that extrapolate mortality using data below age 75 or 
even 85 are likely to produce very unreliable results. For that reason for 
my thesis I am thinking of only studying developed countries using the 
Kannisto-Thatcher Database on Old Age Mortality that includes single-age 
mortality data up to age 110+, with time series of up to more than 250 
years . 
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Annex I : Main parameterization functions for mortality26 
 
 
 
 
 
 
                                                 
26 Taken from Tabeau E (2001) 
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Note: In this table the standard demographic notation is used. The survival 
function s is such that for continuous x, s(x) is the probability of survival from 
birth until age x. The life table symbol l(x) is the empirical equivalent of the 
function s(x). The probability that a person x will survive to age x+1 is p(x)= 
s(x+1)/s(x) and the probability that a person aged x dies before reaching age x+1 
is q(x)=1-p(x). The force of mortality, also known as mortality intensity µ (x) = -
(ds(x)/dx)/s(x). The symbol m(x) is used for its empirical equivalent, the mortality 
rate. The symbol e(x) denotes life expectancy at age x, ω is the highest attainable 
age, and the remaining symbols are model parameters. 
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Annex II : Main parameterization functions for old age mortality27 
 
 
 
  
 
 
Note: All the functions are formulated in terms of the force of mortality 
µx. For the sake of simplicity of the calculations, the force of mortality µx 
has been replaced by the central death rate mx. One function 
(Helligman-Pollard) is specified for the probability of dying qx. 
 
 
 
 
                                                 
27 Taken from Boleslawski & Tabeau  (2001) 
 
